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ABSTRACT 
Max Tze-Han Huang: Critical roles of inflammasome components NLRs, PYCARD and 
Caspase-1 in host – pathogen interactions 
(Under the direction of Jenny P.-T. Ting) 
 
The sensors of innate immune defense are indispensible in the fight against 
foreign and self insults. Three classes of pattern recognition receptors (PRRs) including Toll-
like receptors (TLRs), nucleotide binding domain leucine-rich repeat containing receptors 
(NLRs) and RIG-I-like RNA helicases (RLHs) are designed to recognize conserved 
microbial moieties called pathogen associated molecular patterns (PAMPs). Recent 
discoveries on the understanding of the functions of NLRs have advanced our knowledge of 
how intracellular pathogens are detected and the subsequent host cell mediated immunity. At 
least four members of the NLR family can form multi-protein complexes termed 
inflammasomes and initiate downstream functions such as IL-1β/IL-18 processing and cell 
death execution. In this dissertation, the roles of NLRs and their interacting partners in 
combating Porphyromonas gingivalis and Francisella tularensis and how these pathogens 
target host signaling pathways to overcome host defense were examined. In part I, we 
showed in the absence of NLRP3, PYCARD/ASC or Caspase-1, human  
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monocytic THP-1 cells are unable to release IL-1β when confronted with P. gingivalis. P. 
gingivalis also induces necrotic like cell death in THP-1 cells and this process requires 
NLRP3 and PYCARD. In part II, we showed that Francisella tularensis suppresses host 
immune cytokine release of IL-1β and TNF-α. RipA, a F. tularensis membrane protein, is 
critical in this process. F. tularensis (Live Vaccine Strain) LVS ripA deletion mutant 
(LVSΔripA) fails to suppress the release of IL-1β and TNF-α. We showed that LVS activates 
host signaling pathways including inflammasomes and MAP Kinases and ripA is critical in 
these processes. Furthermore, the absence of ripA in LVS allows a robust immune responses 
against this organism in vivo. Taken together, the works in this dissertation demonstrated, for 
the first time, that NLRs play a critical role in cell mediated host defense against P. gingivalis 
and elucidated a mechanism by which F. tularenesis targets and suppresses host immune 
response in the release of pro-inflammatory cytokines. 
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1.1 Overview 
An enormous challenge for the immune system is to recognize a wide array of 
foreign insults including bacteria and virus. Pattern recognition receptors such as the Toll-
Like Receptors (TLRs), RIG-I-Like Receptors (RLRs), and Nucleotide-binding domain and 
Leucine-Rich Repeats containing proteins (NLRs) play a critical role in host detection of 
pathogens. Recent discoveries have implicated NLRs in recognizing intracellular danger 
signals and mounting an innate immune defense. A crucial role of NLRs is their participation 
in sensing pathogens and activating a multi-protein complex termed the inflammasome to 
process and release the pro-inflammatory cytokines IL-1β and IL-18. The activation of 
inflammasomes containing NBD-LRR sensors (NLRs) or non-NLR sensors is critical for 
effective host defense against microbial pathogens. In this introduction, the historical origins 
of NLRs and inflammasomes are discussed in the context of a variety of host-pathogen 
interactions. Additionally, recent discoveries have uncovered a plethora of viral and bacterial 
strategies to inhibit inflammasome-mediated processing of IL-1β and IL-18. The mechanisms 
of viral and bacterial manipulation of IL-1β production ranging from perturbation of caspase-
1 activation to prevention of inflammasome assembly are discussed.  These discussions are 
relevant to the focus of this thesis which is on inflammasome activating pathogens and 
pathogen products that inhibit the inflammasome as an immune evasion mechanism. 
 
 
1.2 Innate immune activation of IL-1β against pathogens 
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The innate immune response stands at the forefront of detecting “danger” 
signals whether they are foreign or host-derived. This response can become activated by 
motifs characteristic of harmful stimuli while ignoring non-pathogenic signals. The innate 
immune system contains a series of germline-encoded pattern-recognition receptors (PRRs) 
which can detect a wide array of pathogen-associated molecular patterns (PAMPs) that are 
present in viral and bacterial cell structures. These sensors include Toll-Like Receptors 
(TLRs), RIG-I-Like Receptors (RLRs), and Nucleotide-binding domain and Leucine-Rich 
Repeats containing proteins (NLRs). Many cell types which survey the vasculature and 
tissues, including monocytes, macrophages, dendritic cells, neutrophils, epithelial cells, T 
cells and B cells, express PRRs.   
The innate immune system also involves the production of cytokines which 
act as messengers to transmit an inflammatory signal to other tissues, activate the innate 
immune system, and induce an anti-viral state.  One such cytokine is IL-1β.  IL-1β is critical 
in host defense against pathogens including bacteria, virus, fungi and parasites (Dinarello 
2009). It is now generally believed that IL-1β is regulated by a two-step signaling process 
(Davis and Ting 2010). The first step is the transcriptional activation and protein synthesis of 
pro-IL-1β.  In this step, TLRs are activated and subsequent activation of MyD88-dependent 
pathways lead to the induction of NF-κB and MAP kinase. This causes the translocation of 
p65, an NF-κB subunit from the cytosol to the nucleus. Additionally, it results in the 
phosphorylation of ERK, JNK and p38 leading to the activation of AP-1 and pro-IL-1β 
transcription.  A second and separate signal results in the subsequent activation of caspase-1, 
leading to the processing and release of IL-1β.  This signal is the result of assembly of one of 
many inflammasomes, which will be detailed below.   
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1.3 The role of the inflammasome in combating pathogens 
The NLR family of proteins was first discovered by a human genome wide 
search for CIITA related sequences (Harton 2002). The result was the identification of a 
family characterized by the presence of several evolutionarily conserved domain structures.  
NLR proteins possess three distinctive domains: an N-terminal variable domain such as pyrin 
(PYD) or caspase recruitment domain (CARD), a central nucleotide binding and 
oligomerization domain (NACHT), and a C-terminal leucine-rich repeat domain (LRR). The 
PYD or CARD domains are thought to be responsible for homotypic interactions that lead to 
the downstream effector functions. The LRRs, similar to those of TLRs, are postulated to 
sense the presence of pathogen or host-derived danger signals, although no conclusive NLR 
ligand-receptor binding interactions have been demonstrated. The NACHT domain, which is 
the only structure shared by all of the NLR family members, is crucial for the nucleotide 
binding-induced oligomerization. The NLR family of proteins was previously named the 
CATERPILLER (CARD, Transcription Enhancer, R (purine)-binding, Pyrin, Lots of Leucine 
Repeat) family and the NOD-like receptor (nucleotide-binding oligomerization domain-like 
receptor) family of proteins. To this date, 22 members of this family have been described 
(Ting 2008). While the functions of the vast majority of NLRs remain poorly understood, 
several NLRs have been demonstrated to play a critical role in host defense against 
pathogens (Pedra 2009).  
The best characterized function of the NLR proteins is their participation in 
sensing a variety of host- and pathogen-derived molecular motifs and processing and release 
of pro-inflammatory cytokines IL-1β and IL-18 via caspase-1-mediated processing. Upon 
stimulation, it is generally thought that a NLR protein changes its conformation to generate 
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an active state and that this conformational change allows the recruitment of the adaptor 
protein PYCARD / ASC (Apoptosis-associated Speck-like protein containing a CARD, also 
known as TMS1) (Masumoto 2000, Conway 2000). PYCARD is a small bipartite protein 
consisting of an N-terminal PYD domain and a C-terminal CARD. Via a CARD-CARD 
homodimeric interaction, PYCARD can then interact with pro-caspase-1 to form a large 
multimeric protein complex that is termed inflammasome (Figure 1.1).  Inflammasome 
formation then regulates caspase-1 activity and the subsequent maturation of pro-IL-1β to 
processed IL-1β for release.  
The inflammasome was first identified and characterized by Martinon and 
coworkers in a seminal study in 2002 (Martinon 2002). Using a cell-fee system, the authors 
demonstrated the assembly of a complex composed of caspase-1, caspase-5, PYCARD and 
NLRP1 that serves as the machinery to process IL-1β. Furthermore, the immune-depletion of 
PYCARD in activated cells blocked the activation of caspase-1 and the subsequent 
maturation of IL-1β. Soon after, inflammasomes were shown to be a platform that host 
macrophages utilize to detect intracellular pathogens and mount an IL-1β and IL-18 
response. Mariathasan and coworkers demonstrated that in addition to ATP triggered IL-1β 
processing, PYCARD played a critical role in Salmonella typhimurium induced caspase-1 
activation and IL-1β release (Mariathasan 2004). Furthermore, macrophages deficient in the 
NLR gene Nlrc4 also demonstrated impaired caspase-1 activation and IL-1β release 
implicating Nlrc4 as the putative NLR sensor for S. typhimurium. From this point, the 
identification of a wide range of intracellular pathogens and their respective host NLR 
counterparts swiftly followed.  
NLRP3 Inflammasome 
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Perhaps the best characterized inflammasome is the NLRP3 (NALP3, 
cryopyrin, CIAS1, PYPAF1, CLR1.1) inflammasome.  This inflammasome is composed of 
NLRP3, PYCARD and caspase-1(Figure 1.1). The NLRP3 inflammasome has been 
implicated in the detection and activation of caspase-1 and processing of IL-1β in response to 
diverse pathogens such as S. aureus, L. monocytogenes, P. gingivalis, M. tuberculosis, K. 
pneumonia, N. gonorrhoeae, C. trachomatis, Sendai virus, Influenza A virus, Modified 
Vaccinia virus Ankara (MVA), and C. albicans (Abdul-Sater AA 2009). Mariathasan and 
coworkers demonstrated that macrophages deficient in Nlrp3 were unable to activate 
caspase-1 and release IL-1β when responding to TLR agonists combined with ATP, bacterial 
toxins such as nigercin and maitotoxin, and bacteria such as S. aureus, L. monocytogenes 
(Mariathasan 2006). In addition, NLRP3 detects non-pathogen derived danger signals such as 
extracellular ATP (Mariathasan 2006), uric acid crystals (Martinon 2006), hyaluronan 
(Yamasaki 2009), and amyloid-β peptides (Halle 2008) leading to the assembly of 
inflammasome.  
Three distinctive modes of NLRP3 activation have been proposed (Schroder 
2010). First, extracellular ATP activates the ion-gated channel P2X7 receptor which recruits 
Pannexin-1to form a pore-forming channel leading to potassium efflux and ultimately to the 
assembly of the NLRP3 inflammasome with various agonists. In the second model, the 
internalization of the agonists such as asbestos via phagocytosis results in lysosomal damage 
and the subsequent NLRP3 inflammasome activation. Thirdly, danger signals induce the 
release of Reactive Oxygen Species (ROS) and the subsequent assembly of the NLRP3 
inflammasome. While the precise source of ROS remains unclear, NADPH appears to play a 
major role as a defect in NADPH blocks the asbestos- and silica-induced activation of the 
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NLRP3 inflammasome (Dostert 2008). Since there is a wide diversity of agonists that 
induces NLRP3 inflammasome formation, perhaps it suggests that NLRP3 does not directly 
detect a structural motif, rather it acts as an adaptor to funnel multiple ligand-induced cellular 
responses to activate an inflammasome. 
 
NLRP1 Inflammasome 
NLRP1 (NALP1, CARD7, DEFCAP, CLR17.1) has a structure that is 
composed of an N-terminal PYD domain followed by a NACHT domain, LRRs, a FIIND 
domain and a C-terminal CARD (Figure 1.1).  This unique structure allows NLRP1 to 
directly interact with caspase-1 to process IL-1β without the aid of PYCARD although the 
presence of PYCARD can enhance the NLRP1 inflammasome activity (Lamkanfi 2009). 
Both muramyl dipeptide (MDP) and anthrax lethal toxin have been shown to activate the 
NLRP1 inflammasome. NLRP1 has three highly polymorphic orthologs in mouse (Nlrp1a-c) 
(Boyden 2006). Differential expression of these genes results in differential susceptibility to 
anthrax lethal toxin among various inbred mouse strains. Murine macrophages derived from 
strain 129 solely express Nlrp1b and therefore are highly responsive to anthrax lethal toxin 
challenge, undergoing cell death and releasing high levels of IL-1β when pretreated with LPS 
unlike other strain such as C57BL/6 (unpublished results).  
NLRC4 Inflammasome 
A third well-described inflammasome is the NLRC4 inflammasome.  NLRC4 
(IPAF, CLR2.1, CLAN) has a structure composed of an N-terminal CARD, a central 
NACHT and a C-terminal LRR, and this gene is highly expressed in myeloid cells (Figure 
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1.1). The activation of NLRC4 leads to caspase-1 activation, release of IL-1β and IL-18 as 
well as cell death. NLRC4 has been implicated in host defense against S. typhimurium, L. 
pneumophila, and P. aeruginosa (Sutterwala 2009). Interestingly, in addition to NLCR4, 
another NLR, Naip5/Birc1e has been shown to be involved in the host defense against L. 
pneumophila (Zamboni 2006). One way to explain the need for both NLRC4 and Naip5 in 
defense against this pathogen is the demonstration that NLRC4 and Naip5 physically 
interact, suggesting NLRC4 and Naip5 jointly regulate caspase-1 activation in response to L. 
pneumophila. Until recently, a feature that differentiated the mechanisms of caspase-1 
activation downstream of NLRP3 and NLRC4 was that while the activation of NLRP3 
required potassium efflux, NLRC4 inflammasome did not. However, a recent study 
demonstrates that non-flagellated P. aeruginosa- induced caspase-1 activation could be 
blocked by raising the extracellular potassium concentration suggesting that the NLRC4 as 
well as NLRP3 and other inflammasomes may all require potassium efflux to trigger the 
assembly of inflammasome (Arlehamn 2010, Fernandes-Alnemri 2010).  In addition, while 
previous work suggests that NLRP3 has a wide range of agonists, NLRC4 has a restricted 
specificity. More recent data suggest that NLRC4 detects a conserved motif found in the rod 
protein, a component of Type III Secretion System, of Salmonella typhimurium, 
Burkholderia pseudomallei, Escherichia coli, Shigella flexneri, and Pseudomonas 
aeruginosa (Miao 2010). This suggests that NLRC4 has the ability to discern pathogenic 
entities from host motifs.    
AIM2 Inflammasome 
Another PAMP sensor, Absent In Melanoma 2 (AIM2) was first discovered in 
a screening of novel cDNAs expressed in a chromosome-suppressed melanoma cell line 
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(DeYoung 1997). It is a member of the HIN-200 interferon-inducible family of proteins and 
has a structure consisting of an N-terminal PYD and a C-terminal HIN-200 domain which 
features two nucleotide binding regions (Figure 1.1). AIM2 is expressed in the cytoplasm 
where it can bind to its ligand, cytoplasmic DNA.  Following ligand binding, AIM2 
oligomerizes and forms a large structure, the ASC speck / PYCARD pyroptosome, with 
PYCARD via PYD-PYD homotypic interaction (Fernandes-Alnemri 2009, Roberts 2009). 
The formation of the PYCARD pyroptosome leads to the activation of caspase-1 and 
subsequent processing and release of IL-1β similar to other previously described 
inflammasomes. Murine macrophages deficient in Aim2 are unable to process and release IL-
1β upon synthetic cytoplasmic DNA stimulation with poly dA:dT while NLRP3 and NLRC4 
signaling remains unaffected (Fernandes-Alnemri 2010). Vaccinia-induced caspase-1 
activation and IL-1β release have also been demonstrated to be AIM2 dependent (Rathinam 
2010). Vaccinia virus is a dsDNA member of the orthopoxvirus family that is able to 
replicate in the cytoplasm. 
Recently, AIM2 has also been implicated in the detection of DNA from 
bacterial pathogens of the genus Francisella tularensis sub-species novicida (F. novicida) 
(Fernandes-Alnemri 2010). F. tularensis is a facultative intracellular pathogen that causes 
tularemia and is a potent bio-terrorism agent. F. tularensis enters host macrophages via 
phagocytosis and escapes the phagosome-lysosome complex into the cytoplasm where it 
replicates. Once in the cytoplasm, F. novicida triggers an IRF3 dependent type I interferon 
response that ultimately leads to the activation of caspase-1 and the release of IL-1β 
(Henry2007). AIM2 has been shown to be important for the detection of DNA of F. novicida 
and subsequent IL-1β release (Fernandes-Alnemri 2010). Fernandes-Alnemri and coworkers 
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demonstrated that macrophages deficient in Aim2 are unable to release IL-1β upon infection 
with the related pathogen F. novicida, and the absence of Aim2 elevated the susceptibility of 
animals to subcutaneously administered F. novicida. Mechanistically, it is postulated that F. 
novicida DNA could be released when the bacteria are lysed and that this DNA enters the 
cytoplasm at the same time as live bacteria via phagosomal escape. Accumulating evidence 
suggests F. tularensis suppresses the release of IL-1β and possibilities exist that F. 
tularensis, via unknown mechanisms, prevents AIM2 from recognizing its bacterial DNA.  
However, studies of the role of AIM2 in F. tularensis remain to be carried out. 
 
 
1.4 Inflammasome inhibition as a pathogenic stealth mechanism 
As described above, IL-1β is critical in the host defense against a number of 
bacteria and viruses, however pathogens have evolved mechanisms to prolong their survival 
by inhibiting IL-1β transcription and by producing IL-1β decoy receptors (Dinarello 2009). 
Additionally, recent studies have revealed an increasing number of pathogenic virulence 
factors that function to target the inflammasome and inhibit IL-1β processing. Examples of 
the mechanisms by which viruses and bacteria repress inflammasome activation to inhibit IL-
1β secretion are outlined within the context of the two-step activation of IL-1β (Fig. 1.2). 
Additionally, specific information about the genes involved is provided in the sections below 
and summarized in Table I. Since host inhibition of the inflammasome has many parallels to 
pathogen-mediated inhibition of the inflammasome, the former will be briefly discussed. 
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1.5 Host derived inhibition of the inflammasome 
Host suppression of the inflammasome is essential since prolonged 
inflammatory response beyond eradication of a foreign or self-insult can lead to excessive 
tissue damage. Pathways of deactivation are important to understand since they provide 
potential targets or mimics for pathogens in their attempts to achieve immune stealth by 
minimizing the inflammatory response. Since PYCARD is an adaptor molecule shared by a 
variety of NLR and non-NLR inflammasome complexes, a PYCARD-binding molecule 
provides an attractive target for deactivation of the inflammasome. One well-characterized 
family of inhibitors of PYCARD is the cellular PYRIN domain (PYD)-only proteins (POP) 
family. Mammalian cPOP1 and cPOP2 disrupt inflammasome activation by binding 
PYCARD and blocking its interaction with NLRs (Stehlik 2003, Dorfleutner 2007, Bedoya 
2007). The serpin proteinase inhibitor 9 (PI-9), on the other hand, directly inhibits caspase-1 
activity through protein-protein interaction (Young 2000). PI-9 is expressed by vascular 
smooth muscle cells and a variety of normal tissues, and its expression correlates inversely 
with that of IL-1β. Caspase-12 also can directly associate with caspase-1 to inhibit its 
activity. Polymorphisms in the human caspase-12 gene confer increased sepsis (Saleh 2004), 
and its deficiency in mice impedes bacterial clearance (Saleh 2006). An additional class of 
host inflammasome inhibitors is represented by the Bcl family of cell survival proteins. Bcl-2 
and Bcl-XL can directly bind to NLRP1 to disrupt the activation of its inflammasome and 
subsequent IL-1β processing (Bruey 2007). Another seminal study showed that T cells, in 
addition to profoundly regulating the adaptive immune response, are key regulators of innate 
immunity via the specific inhibition of inflammasomes. CD4
+
 T cells inhibit the activation of 
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NLRP3 and NLRP1 inflammasomes but not the NLRC4 inflammasome (Guarda 2009). This 
suppression can be replicated by TNF family ligands such as CD40L. Collectively, these 
studies have expanded our understanding of host mechanisms for suppressing inflammasome 
activation and have provided rationales for pathways that pathogens have evolved to target. 
 
 
1.6 Viral inhibition of the inflammasome 
Poxviruses produce cPOP and serpin homologs that bind and target PYCARD and caspase-1  
In a 2005 study, a PYD containing protein analogous to the host-derived 
cPOP proteins was identified from myxoma virus, a member of the poxvirus family 
(Johnston 2005). This myxoma virus M013 protein is essential for productive viral infection, 
and like cPOP1 and cPOP2, binds PYCARD to prevent inflammasome activation. The 
poxvirus Shope fibroma virus encodes an additional cPOP homolog, gp013L, which like 
M013, co-localizes with PYCARD when transfected into cells, and can also reduce NLRP3-
mediated IL-1β processing in a reconstituted cell system (Dorfleutner 2007).. Both M013 and 
gp013L were shown to possess an additional inhibitory activity on the transcription of IL-1β 
and other pro-inflammatory cytokines through repression of NF-κB (Dorfleutner 2007, 
Rahman 2009). These combined studies demonstrate that the poxvirus vPOPs simultaneously 
target inflammasome activation and NF-κB activation to provide dual regulation of IL-1β at 
the level of transcription and processing. 
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  An additional strategy of poxviruses involves the production of viral serpins 
analogous to the mammalian PI-9 protein (Young 2000). In a landmark study, the cowpox 
gene crmA was identified as a potent host immune suppressor and a specific inhibitor of 
caspase-1 (Ray 1992). Extracts from cowpox infected cells can block the processing of IL-
1β, and this property is lost when crmA is inactivated. Furthermore, purified CrmA protein 
abrogates the proteolytic activity of caspase-1. Vaccinia virus expresses a gene B13R that is 
highly homologous to crmA and is required for inhibition of IL-1β processing in vaccinia-
infected THP1 monocytic cells (Kettle 1997). The myxoma virus counterpart of CrmA and 
B13R, Serp2, immunoprecipitates with caspase-1, suggesting that direct interaction may 
mediate the inhibitory function of the poxvirus serpins (Petit 1996). A similar caspase-1 
inhibiting protein is encoded by ectromelia virus, a murine orthopoxvirus (Turner 2000). 
Thus the production of serpin PI-9 homologs appears to be an evolutionarily preserved and 
advantageous inhibitory mechanism adopted by multiple viruses to subvert host immunity. 
Additional viral proteins that inhibit inflammasome activity  
  A dsRNA virus and a member of the Orthomyxoviridae, influenza A virus 
encodes approximately 10 proteins, among which the non-structural protein NS1 is critical 
for evasion of host immune defense (Stasakova 2005). NS1 is a 26KD protein that dimerizes 
to prevent nuclear export of host mRNA, activation of protein kinase (PKR) and the type I 
interferon response. Viruses expressing NS1 bearing mutations within the RNA binding and 
dimerization domains induce significantly elevated levels of caspase-1 activation and IL-1β 
and IL-18 secretion in primary human macrophages, suggesting that NS1 constitutes an 
additional viral protein that inhibits inflammasome activation. 
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Baculovirus expresses the antiapoptotic protein p35 which also can inhibit 
caspase-1 (Bump 1995). Co-expression of p35 with caspase-1 in a cell line that constitutively 
expresses pro-IL-1β decreases the release of IL-1β. Furthermore, purified recombinant p35 
can inhibit the enzymatic activity of caspase-1. To date, this protein has no identifiable 
structural domains and no known human homolog, thus it could potentially comprise a novel 
class of inflammasome inhibitors. 
 
 
1.7 Bacterial inhibition of the inflammasome 
Pseudomonas aeruginosa and Yersinia species utilize the T3SS to prevent inflammasome 
activation 
The Type III secretion system (T3SS) provides a mechanism for inserting 
bacterial virulence factors into the host cell, and it is not surprising that this system is 
exploited by several bacteria to minimize the inflammasome response. Pseudomonas 
aeruginosa induces NLRC4-dependent IL-1β release, however one strain of P. aeruginosa, 
PA103, fails to induce caspase-1 activation and IL-1β release (Sutterwala 2007). This effect 
was shown to be mediated by the T3SS effector molecule Exoenzyme U (ExoU). The ability 
of ExoU to suppress caspase-1 is attributed to its phospholipase activity, though it is not clear 
how this activity relates to its inhibitory function. ExoS also negatively regulates caspase-1-
mediated IL-1β processing (Galle 2007). Interestingly, ExoS is a bifunctional protein with an 
N-terminal Rho GTPase domain and a C-terminal ADP-ribosyltransferase domain that could 
act to inhibit immune function. 
15 
 
Yersinia also produces a set of T3SS effector molecules, the Yops, that can 
modulate inflammasome response. Y. enterocolitica deficient in YopE and YopT induces 
elevated caspase-1 maturation and IL-1β secretion in a murine macrophage cell line (Schotte 
2004). Furthermore, YopE and YopT were found to modulate the oligomerization of caspase-
1. Like ExoS of P. aeruginosa, YopE serves as a Rho GTPase activating protein, while YopT 
is a cysteine protease. Though the relevance of these activities to caspase-1 inhibition is 
unclear, this suggests a commonality in function of the T3SS effector molecules in blocking 
inflammasome activation. 
A recent study shows that YopK of Y. pseudotuberculosis has an entirely 
unique mechanism for interfering with inflammasome activation (Brodsky 2010). The T3SS 
of Y. pseudotuberculosis activates NLRP3 and NLRC4-dependent caspase-1 processing, but 
YopK associates with the T3SS translocon to mask its detection by the inflammasome. This 
is significant because it represents the first study where an effector molecule binds to T3SS 
to avoid host detection. It is likely that analgous proteins may exist for other T3SS bacteria. 
 
Mycobacterium tuberculosis produces a Zn
2+ 
metalloprotease that inhibits inflammasome 
activation by NLRP3 inflammasome inducers 
IL-1β is not highly activated during infection with Mycobacterium 
tuberculosis (Mtb) or related Mycobacterium species such as the vaccine strain 
Mycobacterium bovis BCG. The BCG gene zmp1 encodes a Zn
2+ 
metalloprotease that is 
required for its suppression of IL-1β processing (Master 2008). BCG infection also prevents 
the activation of caspase-1 triggered by the simultaneous administration of NLRP3 
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inflammasome agonists nigericin and ATP. This is a significant finding because it suggests 
that BCG undergoes an active process to repress inflammasome activation induced by an 
independent second signal. Interestingly, caspase-1
-/-
 mice infected with Mtb exhibit wt 
levels of both pro-IL-1β and processed IL-1β. Despite the persistance of IL-1β, these mice 
display elevated lung burdens and decreased survival compared to wt mice (Mayer-Barber 
2010). This suggests that caspase-1 plays other protective roles in Mtb infection besides IL-
1β processing, such as regulating cell death. 
Streptococcus pneumoniae produces a pore-forming toxin that suppresses the inflammasome 
Streptococcus pneumoniae utilizes a number of virulence factors for 
successful colonization. Among these, the cholesterol-dependent pore-forming exotoxin, 
pneumolysin, is implicated in S. pneumoniae-induced host tissue damage. Pneumolysin-
deficient bacteria induce elevated caspase-1 activation and IL-1β secretion in human DCs 
(Littmann 2009). This is surprising since other pore-forming toxins, by contrast, are known 
to activate caspase-1 (Cordoba-Rodriguez 2004, Craven 2009). Pneumolysin-deficient S. 
pneumoniae also exhibit elevated levels of immature IL-1β, suggesting that pneumolysin 
modifies host cell signaling pathways such NF-κB or MAP kinase to simultaneously 
suppress the expression and processing of IL-1β. 
 
 
1.8 Concluding Remarks 
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Throughout evolution, pathogens have developed mechanisms to circumvent 
host immune detection via a wide range of strategies. Since IL-1β is critical in the effort to 
eradicate foreign microbial infection, inflammasome-mediated signaling pathways provide 
an obvious target for achieving pathogenic stealth by minimizing the host immune response. 
Though IL-1β appears to function as the primary target for pathogen-mediated 
inflammasome inhibition, studies with Mtb demonstrate that inflammatory processes other 
than IL-1β processing, such as pathogen-mediated cell death, may be targeted for the benefit 
of the pathogen. Viruses and bacteria inhibit multiple stages of inflammasome activation. 
Poxviruses produce cPOP homologs that directly bind PYCARD and thereby prevent 
inflammasome assembly. Additionally, abundant evidence points to caspase-1 as a prime 
target for suppression of IL-1β production; however in many cases it not known whether 
caspase-1 is directly targeted or whether an unknown upstream mediator is involved. NLRP1 
is a target for host Bcl family proteins (Bruey 2007), however as yet no pathogen-derived IL-
1β inhibitors have been shown to function through direct interaction with an NLR component 
of the inflammasome. It is intriguing that several pathogen-encoded proteins show specificity 
for particular NLR inflammasome pathways, suggesting that such regulators may exist. The 
pathogen-derived inflammasome inhibitors identified thus far range from serpins to enzymes 
to pore forming toxins, suggesting that the mechanisms that have evolved to perturb the 
inflammasome are widespread. In each of the examples presented, inflammasome inhibition 
is beneficial to the pathogen, however it is possible that in cases of excessive inflammasome 
activation leading to tissue destruction inhibition might be beneficial to the host. Future 
challenges include the elucidation of mechanisms connecting pathogen-derived ligands to 
caspase-1 activation. For example, in most cases it has not been determined whether 
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pathogenic proteins affect inflammasome assembly, the function of the mature caspase-1 
protein, or an upstream mediator of the inflammasome. Elucidation of these mechanisms will 
lead to the development of novel approaches towards controlling infectious diseases and 
other inflammasome-dependent inflammatory processes.
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Table 1. Examples of bacteria and viruses that inhibit IL-1β release as a pathogenic stealth 
mechanism.  
gene/Protein Pathogen Classification Function References 
M013  Myxoma virus cPOP homolog Binds to PYCARD and 
inhibits inflammasome 
activation, Inhibits caspase-1 
activation  
Johnston, 2005  
gp013L Shope fibroma virus cPOP homolog Binds to PYCARD and 
inhibits inflammasome 
activation 
Dorfleutner, 2007 
crmA Cowpox virus Serpin Inhibits caspase-1 activation Ray, 1992 
B13R Vaccinia virus Serpin Inhibits caspase-1 activation Kettle, 1997 
Serp2 Myxoma virus Serpin Binds caspase-1 and inhibits 
caspase-1 activation  
Petit, 1996 
SPI-2 Ectromelia virus Serpin Inhibits caspase-1 activity Turner, 2000 
NS1 Influenza A virus ds RNA-binding 
protein 
Inhibits caspase-1 activation Stasakova, 2005 
p35 Baculovirus Unknown Inhibits caspase-1 activation Bump, 1995 
YopE Yersinia GTPase- Inhibits IL-1β, caspase-1 Schotte, 2004 
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enterocolitica  activating protein activation/oligomerization 
YopT Yersinia 
enterocolitica  
Cysteine protease Inhibits IL-1β, caspase-1 
activation/oligomerization 
Schotte, 2004 
YopK Yersinia 
pseudotuberculosis 
 Binds to T3SS and prevents 
inflammasome activation 
Brodsky, 2010 
ExoU Pseudomonas 
aeruginosa PA103 
Exoenzyme Inhibits IL-1β, caspase-1 
activation within the NLRC4 
inflammasome 
Sutterwala, 2007 
ExoS Pseudomonas 
aeruginosa 
Exoenzyme Inhibits IL-1β, caspase-1 
activation 
Galle 2008 
zmp1 Mycobacterium 
tuberculosis/BCG 
Zn
2+
 
metalloproteinase 
Inhibits IL-1β, caspase-1 
activation by NLRP3 
inducers 
Master, 2008 
Pneumolysin Streptococcus 
pneumonia 
Pore-forming 
toxin 
Inhibits IL-1β, caspase-1 
activation  
Littmann, 2009 
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Figure 1.1: Basic structures of NLRP1, NLRP3, NLRC4 and AIM2 Inflammasomes. 
 
 
 
 
 
Figure 1.1 Basic structures of NLRP1, NLRP3, NLRC4 and AIM2 Inflammasomes. 
Theorized components of NLRP1, NLRP3, NLRC4 and AIM2 inflammasomes are depicted 
here. Specific agonists activate the inflammasomes leading to the processing and release of 
IL-1β, IL-18 and the execution of cell death. While the activation of NLRC4 inflammasome 
can occur without PYCARD, the presence of PYCARD enhances the activation of the 
NLRC4 Inflammasome. PYD, pyrin domain; NACHT, nucleotide-binding and 
oligomerization domain; LRR, leucine-rich repeat; CARD, caspase recruitment domain; 
HIN, HIN-200/IF120x domain; FIIND, domain with function to find. 
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Figure 1.2: Suppression of the two step regulation of IL-1β production by virus and bacteria. 
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Figure 1.2 Suppression of the two step regulation of IL-1β production by virus and bacteria. 
Host IL-1β release is prompted by a two step process. First, the activation of NF-κB and AP-
1 leads the transcription of pro-IL-1β. A second signal sensed by an NLR triggers the 
assembly of the inflammasome and the subsequent activation of caspase-1. Active caspase-1 
proteolytically processes pro-IL-1β into IL-1β for release. Viruses and bacteria have 
developed an array of strategies to interfere with inflammasome activation. Myxoma and 
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Shope fibroma viruses utilize POP-like proteins M013 and gp013L to bind PYCARD and 
prevent the inflammasome assembly. Poxviruses also express the serpins crmA, Serp2, 
B13L, and SPI-2 which disrupt the proteolytic activity of caspase-1, potentially through 
direct binding to caspase-1. Influenza A virus and baculovirus express NS1 and p35, and Y. 
enterocolitica expresses Yop E and YopT that disrupt caspase-1 oligomerization.. The P. 
aeruginosa effector molecules ExoU and ExoS block the activation of the NLRC4 
inflammasome, while the Mycobacterium tuberculosis gene zmp1 may target the NLRP3 
inflammasome. Pneumolysin of Streptococcus pneumonia also blocks IL-1β release by 
diminishing caspase-1 activity. YopK of Yersinia pseudotuberculosis has a unique 
mechanism in that it binds to T3SS and masks detection by the inflammasome Though each 
of these proteins inhibits caspase-1 activation, it is not known in most cases whether caspase-
1 is directly targeted or whether effects are mediated indirectly by targeting of an upstream 
regulator.  
 
 
 
 
 
 
  
 
 
Chapter II 
 
Critical role of ASC and NLRP3 in causing necrosis and ASC speck formation induced 
by Porphyromonas gingivalis in human cells
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2.1 Abstract 
Periodontal disease is a chronic inflammatory disorder that leads to the 
destruction of tooth-supporting tissue and affects 10-20 million people in the U.S. alone.  The 
oral pathogen Porphyromonas gingivalis (Pg) causes inflammatory host response leading to 
periodontal and other secondary inflammatory diseases. To identify molecular components 
that control host response to Pg in humans, roles for the NLR (NBD-LRR) protein, NLRP3 
(Cryopyrin, NALP3) and its adaptor ASC were studied. The Pg strain A7436 induces cell 
death in THP1 monocytic cells and in human primary peripheral blood macrophages. This 
process is ASC- and NLRP3-dependent and can be replicated by Pg LPS and E. coli. Pg-
induced cell death is caspase and IL-1-independent and exhibits morphological features 
consistent with necrosis including loss of membrane integrity and release of cellular content. 
Intriguingly, Pg-induced cell death is accompanied by the formation of ASC aggregation 
specks, a process not previously described during microbial infection.  ASC specks are 
observed in Pg-infected primary human mononuclear cells and are dependent on NLRP3. 
This work shows that Pg causes ASC and NLRP3-dependent necrosis, accompanied by 
ASC-speck formation.
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2.2 Introduction 
Periodontal disease is an inflammatory disorder that ultimately leads to the 
destruction of tooth supporting tissue and affects 7-15% of the U.S. adult population ( 
Southerland 2000). It is one of the most common chronic infections and has been linked to a 
variety of systemic diseases such as atherosclerosis and other coronary diseases (Offenbacher 
2005). Understanding the host response orchestrated by bacteria is critical in deciphering 
periodontal disease pathogenesis and ultimately in the design of effective therapeutics. One 
of the most frequently isolated oral micro-organism in periodontal diseased tissue is 
Porphyromonas gingivalis (Pg
3
), a gram-negative anaerobic bacterium. During an infection, 
bacteria may directly activate a host cell mediated host response via various bacterial 
products, with Pg-derived lipopolysaccharides (LPS) being a prominent pathogen-associated 
molecule. Monocytes /macrophages present in the periodontal tissues of patients are major 
contributors of host response during periodontal diseases (Zhou 2005). In addition to 
monocytes/macrophages, other immune cell types such as keratinocytes, fibroblasts, 
dendritic cells and endothelial cells also play a role in producing cytokines (Graves 2008, 
Steinberg 2006, Palmqvist 2008). Gingival crevicular fluid (GCF) obtained from diseased 
tissues of patients with periodontal disease exhibited elevated levels of IL-1, IL-8 and IL-10 
cytokines (Gamonal). Furthermore, Pg LPS has been shown to be an agonist of the pathogen-
associated molecular pattern receptors, TLR2 and TLR4 (Wang 2007, Hashimoto 2004, 
Bainbridge 2002, Al-Qutub 2006, Coats 2003, Reife 2006). In addition, other bacterial 
products such as fimbriae have been shown to induce host immunity via TLR2 
(Hajishengallis 2008, Gibson 2004). TLR2 is also critical in Pg induced alveolar bone loss in 
mice (Burns 2006).  
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Recently, new proteins that are members of the NLR (nucleotide-binding 
domain leucine-rich repeat, or NBD-LRR) family 
(http://www.genenames.org/genefamily/nacht.html) (Ting 2008) have been identified as 
important regulators of the host response to pathogens and their components. This family was 
previously named as the CATERPILLER (CARD, Transcription Enhancer, R (purine)-
binding, Pyrin, Lots of Leucine Repeat), NOD-LRR (nucleotide-binding oligomerization 
domain leucine rich repeat containing), NOD-like receptor (nucleotide-binding 
oligomerization domain-like receptor, also NLR), or NACHT-LRR (NAIP, CIITA, Het-E-1, 
TLP1, leucine rich repeat) family (Franchi 2008, Mariathasan 2007, McDermott 2007). NLR 
proteins contain 3 evolutionarily conserved domains: a variable N-terminal domain, a 
nucleotide binding domain and a C-terminal leucine rich repeat region. To date, over 20 NLR 
family members have been identified in humans, and roles in immunity have been elucidated 
for several. One of the best-characterized family members is NLRP3 (formerly cryopyrin).  
Mutations in the NLRP3 gene have been identified in a trio of autoinflammatory disorders, 
collectively named C.A.P.S. (CIAS1-associated periodic syndrome) (Ting 2006). NLRP3 
interacts with an adaptor molecule, ASC (Apoptosis-associated speck-like protein containing 
a CARD, also known as TMS1) (Masumoto 1999, McConnell 2000).  ASC is a small 
bipartite protein consisting of an N-terminal PYRIN domain and a C-terminal CARD 
(caspase recruitment domain).  ASC and NLRP3, together with procaspase-1, form a multi-
protein complex termed the inflammasome (Ting 2006, Petrilli 2005, Martinon 2002). When 
a cell encounters specific pathogens or host danger signals, it is believed that the pyrin 
domain of ASC interacts with the pyrin domain of NLRP3, while the CARD domain 
interacts with the CARD domain of procaspase-1(Martinon 2002, Srinivasula 2002). This 
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leads to the activation of caspase-1 and subsequent maturation of pro IL-1 to mature IL-1 
for release.  
 
In addition to IL-1 processing, NLRP3 and ASC mediate pathogen induced 
cell death (Mariathasan 2005, Willingham 2007). ASC was first isolated and characterized in 
monocytic HL60 cells undergoing apoptosis (Masumoto 1999, Ohtsuka 2004). 
Overexpression of ASC is known to cause mitochondrial-dependent apoptosis which can be 
blocked by dominant negative caspase-9 but not dominant negative caspase-8 (McConnell 
2000). In non-hematopoietic cells, ASC has been demonstrated to be an adaptor of bax in 
p53 mediated apoptosis pathways (Ohtsuka 2004). Macrophages derived from ASC deficient 
mice have been shown to be resistant to cell death when exposed to Francisella tularensis 
(Mariathasan 2005). These authors speculated that macrophages undergo cell death when 
infected with F. tularensis as a last line of defense to prevent bacteria from replicating 
intracellularly. Another report shows that Shigella flexneri induces NLRP3 and ASC 
dependent necrosis that results in the release of proinflammatory mediators such as HMGB1 
(Willingham 2007).  The nature of cell death is critical as necrotic cell death exacerbates 
local inflammation while apoptotic cells elicit minimal impact within the microenvironment. 
Since ASC and the inflammasome clearly play an important role in the cell death elicited by 
multiple human pathogens, we hypothesized that they might also be important in Pg induced 
cell death mechanisms. In addition, since mechanisms of Pg elicited cell death have not yet 
been clearly defined, we sought to characterize Pg-induced cell death in the context of the 
inflammasome.  
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The present study shows that Pg induces a necrotic-like cell death in THP1 
cells and primary human macrophages and that ASC and NLRP3 are both important for Pg 
induced cell death. This form of cell death is accompanied by the formation of a large ASC-
complex in dying cells, representing the first observation of an ASC speck aggregate in 
response to a microbial pathogen. 
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2.3 Results 
Pg induces cell death in THP1 monocytic cells 
To determine whether Pg induces cell death in human monocytes/ 
macrophages, we infected THP1 cells with Pg strain, A7436 (Genco 1991) and measured cell 
death using a propidium iodide (PI) exclusion assay.  Cell death is reflected by the loss of 
membrane integrity and corresponding uptake of the fluorescent dye.  A Hoechst 33342 stain 
was simultaneously used to reveal all cells in the sample. Pg induced a dose-dependent cell 
death in THP1 cells as visualized by increased PI staining (Figure 1A). Results are quantified 
in Figure 1B. In the absence of pathogen exposure, approximately 2-5% of cells were PI-
positive, indicating a low basal level of cell death.  Exposure to Pg caused a reproducible and 
time-dependent increase in cell death. Exposing THP1 cells for 48 hours caused 8-16% of 
cells to undergo cell death (grey bars), while exposure for 72 hours caused 16-25% cell death 
(black bars). Viability assays demonstrate that Pg can still be recovered 24, 48 and 72 hours 
post exposure to THP1 (Figure 1G). These findings suggest that Pg can cause cell death as 
measured by PI exclusion staining, and that some level of Pg remains viable in these 
cultures. 
 
Pg induced cell death in THP1 cells is ASC and NLRP3 dependent 
ASC is a critical regulator of Pg induced release of IL-1 and other cytokines 
in THP1 cells (Taxman 2006). To extend our findings, we tested whether Pg induced cell 
death is ASC dependent. Short hairpin RNA molecules (Sh-RNAs) were designed to promote 
the degradation of ASC mRNA (Sh-ASC).  A control Sh-RNA with a mutated target ASC 
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sequence was also prepared (Sh-CNTRL). Using retroviruses, these Sh-RNAs were stably 
incorporated into THP1 cells, resulting in an approximately 90% reduction of ASC mRNA 
and protein (Taxman 2006, Figures 1C, 1D). We exposed Sh-ASC and Sh-CNTRL cells to 
Pg for 72 hours and measured cell death levels in each cell line. Whereas Sh-CNTRL cells 
underwent significant levels of cell death following infection with 100 and 300 MOI of Pg, 
the level of cell death in Sh-ASC knockdown cells was greatly reduced (Figures 1E and 1F). 
The dose dependency of Pg-induced cell death reached a maximal level at approximately 
150-300 bacteria per cell. However, even after Sh-ASC containing cells were exposed for 72 
hours to 1200 Pg per cell, little cell death was observed (Figure 1F). These differences were 
not explained by differing levels of Pg viability since equivalent amounts of Pg were 
recovered from control and Sh-ASC cell cultures in a viability assay (Fig. 1H). These results 
indicate that ASC is essential for Pg-induced cell death in THP1 cells.  
 
NLRP3 is known to interact with ASC within the inflammasome complex and 
is necessary for IL-1 release and cell death induced by multiple pathogens (Willingham 
2007, Kanneganti 2007, Mariathasan 2006, Sutterwala 2006). To determine whether NLRP3 
is required for Pg induced IL-1 and cell death, two independent Sh-RNAs specific for the 
NLRP3 gene were stably expressed in THP1 cells, Sh-NLRP3 #1 and Sh-NLRP3 #2. 
Analysis by real-time PCR shows that NLRP3 mRNA expression levels were reduced by 
80% in Sh-NLRP3 containing cells as compared to control cells (Figure 2A). NLRP3 protein 
also has been shown to be reduced by the Sh-RNA (Willingham 2007). Based on studies 
using multiple other types of bacterial pathogens, a reduction of NLRP3 would be expected 
to reduce IL-1 production (Willingham 2007, Sutterwala 2006). Indeed, levels of IL-1 
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induction were reduced in cells containing Sh-ASC, as well as both Sh-NLRP3 knockdown 
lines following infection with 50 MOI Pg (Figure 2B). These findings verify the functionality 
of the knockdown. Cytokine is induced at a shorter time course and upon infection with a 
lower dose of Pg, and it was, therefore, important for this study to test the knockdown in the 
context of a cell death assay. To determine whether NLRP3 is required for cell death induced 
by Pg, cells containing Sh-NLRP3 were exposed to Pg and assessed by PI exclusion assay 
(Figure 2C). Cells with an empty vector underwent cell death in a dose-dependent manner; 
however, cells with Sh-NLRP3 did not undergo a significant increase in cell death, even 
when exposed to 300 MOI Pg for 72 hours. These results were verified using a panel of 
control cell lines and ASC and NLRP3 knockdown cell lines targeting two different sites for 
each gene (Figure 2D). The use of two Sh-RNAs for each gene greatly reduces the likelihood 
that these results are due to the off-target effects of Sh-RNA.  These findings indicate that Pg 
induced cell death in THP1 cells is ASC and NLRP3 dependent.  
 
Pg LPS induces an ASC and NLRP3-dependent cell death in THP1 cells 
The immunostimulatory activity of Pg is thought to derive from conserved 
structural components including fimbriae and lipopolysaccharide (LPS) within its cell wall. 
Unlike LPS from E. coli and many other gram-negative bacteria, Pg LPS activates host cells 
through TLR2 and TLR4 (Wang 2007, Bainbridge 2002, Al-Qutub 2006, Coats 2003).  To 
determine whether Pg LPS induces ASC dependent cell death, PI exclusion assays were 
repeated using two different concentrations of ultrapure Pg LPS (Figure 3A). The Pg LPS is 
purified from strain ATCC 33277 according to Coat et.al. 2003 and should be composed of 
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lipidA species that are both agonists of TLR2 and TLR4 (Al-Qutub 2006, Coats 2003). THP1 
cells treated with Pg LPS appeared to clump together, a phenomenon not observed in 
bacteria exposed cells.  The clumping made it difficult to count individual cells, however 
microscopic images (Figure 3A) and quantitation using a less stringent Image J software 
setting (Figure 3B) show that, similar to intact Pg, Pg LPS elicits cell death in THP1 cells 
and this process is ASC and NLRP3-dependent. These findings suggest that the LPS moiety 
of the Pg has a similar biological activity as the whole bacteria in inducing cell death in 
THP1 cells through an ASC and NLRP3-dependent mechanism.  
 
E. coli induces an ASC and NLRP3-dependent cell death in THP1 cells 
To determine whether ASC and NLRP3 participate in cell death induced by an 
alternate gram-negative bacteria, we exposed EV (Empty Vector), Sh-ASC, and Sh-NLRP3 
cells to E. coli and measured cell death (Figure 3C). Ten MOI of E. coli induced more cell 
death than 100 MOI of Pg strain A7436, possibly due to the rapid growth of the bacteria and 
acute nature of infection as compared with Pg. While these bacteria cannot be directly 
compared, results suggest that cell death was dependent on ASC and NLRP3 for both 
pathogens. In contrast, previous reports and our data suggest that F. tularensis and 
Salmonella typhi-induced cell death is ASC dependent but not NLRP3 dependent (Figure 
3D) (Willingham 2007, Mariathasan 2006, Mariathasan 2004). These results suggest that 
similar mechanisms may be involved in the induction of cell death in THP1 cells by Pg and 
E. coli and that dependency on ASC and NLRP3 may be pathogen-specific. Further studies 
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will be necessary to directly compare pathogens at a range of doses and times of infection, 
but these initial sets of studies could imply pathogen specificity. 
 
Pg induced cell death in THP1 cells exhibits features consistent with necrosis 
The PI exclusion results suggest that THP1 cells exhibit a loss of cell 
membrane integrity after 72 hours of Pg exposure.  Data from other laboratories suggest that 
membrane permeabilization during necrotic-type cell death may function to alert the immune 
system to invading pathogens(Fink 2005). To characterize the mechanisms of Pg in inducing 
cell death, we treated THP1 cells with 100 MOI Pg strain A7436 for 72 hours and examined 
cellular changes in morphology by transmission electron microscopy (TEM). As a control, 
cells were treated with staurosporine, a well characterized apoptosis-inducing agent. 
Staurosporine induced features typical of apoptosis, but did not cause a loss of membrane 
integrity (Figures 4A, panel i and ii). In contrast, control THP1 cells (Sh-CNTRL) underwent 
a morphologically distinct form of cell death when exposed to Pg, as evidenced by the 
chromatin condensation and loss of cell membrane integrity (Figure 4A, panel iii). These 
features are typical of necrosis occurring during inflammatory cell death.  By comparison, 
Sh-ASC cells exposed to Pg did not exhibit features of apoptosis, nor did they exhibit the 
compromised membrane typical of necrotic cell death (Figure 4A, panel iv).  These findings 
suggest that THP1 cells exposed to Pg undergo ASC- dependent cell death with features 
morphologically consistent with necrosis. We were unable to demonstrate Pg-induced cell 
death using conventional apoptosis assays including Tunel and DNA laddering. This further 
suggests that Pg induced cell death is necrotic-like rather than apoptotic. 
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Pg induces caspase and IL-1ß independent cell death. 
Caspases have been well characterized in classical apoptotic pathways. Our 
data suggest that Pg induces a proinflammatory necrotic-like cell death rather than apoptosis. 
It is established that most apoptosis can be blocked by Z-VAD-fmk, a pan caspase inhibitor. 
In addition, caspase-1 represents an additional component of the IL-1 inflammasome (Ting 
2006).  We previously showed that pre-treating THP1 cells with either Z-VAD or the 
caspase-1 specific inhibitor Y-VAD, blocked Pg A7436 induced IL-1β (Taxman 2006). To 
determine whether caspases are involved in Pg-induced cell death, we tested if Pg induced 
cell death in THP1 cells could be blocked by pre-treatment with Y-VAD and Z-VAD. 
Pretreatment of cells with 10 µM of either Y-VAD or Z-VAD did not prevent THP1 cells 
from undergoing cell death (Figure 4B). To assess the role of IL-1 in Pg-induced cell death, 
cells were pretreated with Kineret, an IL-1 receptor antagonist. Kineret treatment failed to 
abrogate cell death, suggesting that Pg induced cell death is not mediated by IL-1β signaling. 
This suggests that caspases and IL-1 are not required for Pg-induced cell death.   
 
To determine whether the role of ASC and NLRP3 is limited to inflammatory 
stimuli, we tested whether ASC and NLRP3 also play a role in staurosporine-induced cell 
death. Staurosporine efficiently induced cell death in control cells, Sh-ASC- and Sh-NLRP3–
containing cells (Figure 4C). Differences in levels of cell death induction in the different 
cells lines are not statistically significant as determined by Student’s t-test. This result 
demonstrates the specificity of ASC and NLRP3 in cell death induced by bacteria. 
 
36 
 
PARP cleavage is a classical marker of apoptosis.  To verify results from 
Figure 4C, cells containing Sh-CNTRL and Sh-ASC were assessed for PARP cleavage 
following staurosporine treatment. Both groups of staurosporine-treated cells exhibited 
cleaved PARP in a dose-dependent manner (Figure 4D). If anything, PARP levels were 
somewhat greater in Sh-ASC cells. Thus, ASC could potentially have some role in reducing 
excessive PARP cleavage, but does not appear to be necessary for staurosporine-induced 
PARP cleavage. 
 
Pg induces ASC aggregate speck formation in THP1 cells 
ASC was originally characterized in the HL60 leukemic monocytic cell line 
where it aggregated into a cytosolic speck during cell death (Masumoto 1999). However, 
speck formation has not been previously described in the context of microbial infection.  We 
next investigated whether ASC aggregates in THP1 cells following exposure to Pg. THP1 
cells were treated with Pg and stained with an antibody to endogenous ASC.  Untreated cells 
were uniformly stained with ASC (Figure 5A, panel ii). In samples treated with Pg, two 
populations of cells were observed.  In the first group, ASC aggregated into a single cytosolic 
speck, whereas the remaining population exhibited a uniform ASC distribution without a 
speck (Figure 5A, panel iii and Figure 5B). ASC specks formed 24 hours post infection and 
only one ASC speck was observed in each speck containing cell. This latter observation is 
similar to the findings of Masumoto and coworkers who examined ASC speck formation 
caused by retinoic acid treatment (Masumoto 1999).  Our analyses also revealed that speck-
containing cells appeared to be smaller and rounder when compared to non-speck cells, 
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possibly indicative of cell death. Cells containing the ASC specks were PI negative (data not 
shown).  Since speck formation peaks prior to cell death as measured by the PI exclusion 
assay, this finding could suggest that ASC aggregates into specks prior to the loss of cell 
membrane integrity. 
 
To define the morphology of ASC specks, TEM coupled with immunogold 
anti-ASC antibody labeling were used to examine the ASC speck in Pg infected THP1 cells. 
The data indicate that gold-labeled ASC clusters into an amorphous mass of indiscernible 
structure (Figure 5C). Pg can also be found in cells containing ASC specks suggesting a 
correlation between bacterial engulfment and speck formation (Figure 5D).  
 
Pg induced ASC-aggregate speck formation in THP1 cells is NLRP3 dependent 
Since Pg induced cell death is both ASC and NLRP3 dependent (Figures 1 
and 2), we examined whether NLRP3 is required for Pg induced ASC speck formation. ASC 
and NLRP3 knockdown cells were treated for 24 hours with Pg and at least 10 fields of ≥150 
cells were randomly selected for quantification of specks.  ASC specks were induced by Pg 
infection in control THP1 cells stably expressing an empty vector, but not in cells with either 
Sh-ASC or Sh-NLRP3 (Figure 6A). This suggests that NLRP3 is required for both Pg 
induced cell death and ASC speck formation. To further explore the role of NLRP3 in ASC 
speck formation, we transduced THP1 cells with recombinant adenoviruses designed to 
express NLRP3 WT or a disease-associated, gain-of-function NLRP3 mutant, R260W. The 
NLRP3 R260W protein induces rapid necrotic-like cell death in THP1 cells, whereas the 
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NLRP3 WT induces little or no cell death when overexpressed (Willingham 2007, Fujisawa 
2007). Consistent with these findings, NLRP3 WT did not induce significant speck 
formation, while NLRP3 R260W induced ASC speck formation in  > 90% of the THP1 cells 
as early as 9 hours post transduction (Figure 6B). Specks were quantified at 9 hours post 
transduction since at the 24-hour time point, NLRP3 R260W induced substantial cell death 
and no cells were recoverable for ASC staining. The correlation between increased cell death 
and ASC speck formation with the gain-of-function NLRP3 mutant further supports a role 
for NLRP3 in ASC speck formation.  Unfortunately, currently available anti-NLRP3 
antibodies, both commercial and those produced in our lab, are not optimal for microscopic 
identification of NLRP3 in the ASC specks, thus we cannot directly resolve if NLRP3 is 
contained within in the ASC specks.  
 
Pg induces cell death and ASC specks in primary human peripheral blood macrophages 
To extend these results to untransformed cells, we tested whether Pg induced 
cell death and ASC aggregate speck formation occurs in primary human macrophages.  Pg 
induced time- and dose-dependent cell death in primary human macrophages was measured 
by PI staining (Figure 7A). When compared to THP1 cells, primary human macrophages 
exposed to Pg exhibited a higher level of cell death at the same dose and time of exposure 
(25-50 % cell death). Pg also induced ASC aggregate speck formation in primary human 
macrophages (Figures 7B and C). These experiments demonstrate that Pg-induced cell death 
and ASC speck formation in THP1 cells are recapitulated in primary human cells.  
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2.4 Discussion 
In this study, we investigated the role of NLRP3 and ASC in Pg induced host 
cell death in a human monocytic cell line and primary human peripheral blood macrophages. 
We demonstrate that Pg induces a necrotic-like cell death requiring NLRP3 and ASC but not 
caspases (including caspase-1).  Pg infected cells exhibit characteristics morphologically 
indicative of necrosis, including a loss of membrane integrity and release of cellular contents.  
Pg-induced cell death is accompanied by ASC speck formation, which requires the presence 
of ASC and NLRP3. These findings are significant in that monocytic cells are crucial in the 
pathogenesis of periodontal disease (Zhou 2005). Importantly, Pg induced necrosis and speck 
formation were observed in primary human macrophages. While previous analyses have 
shown that either retinoic acid or the over-expression of ASC induces ASC speck formation 
(Ting 2006, Masumoto 1999), this is the first study to show that ASC speck formation occurs 
specifically in response to a microbial pathogen. The finding that ASC specks also occur in 
response to microbial pathogens indicates that specks are likely to be a biological 
phenomenon during the gingival disease process and potentially during infection in general. 
The ASC speck complex may represent an alternative target in elucidating the mechanisms 
of Pg induced cell death as well as a potential target for therapy during microbial infection.  
 
Our results suggest that Pg induces a time- and dose-dependent cell death in 
THP1 cells and that a robust response occurs 72 hours after infection with 300-600 bacteria 
per cell (Figure 1). Similarly, the Pg strain FDC381 has been shown to require a MOI of 500-
1000 to induce cell death (Roth 2007). Our previous reports indicate that a MOI of 50 is 
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sufficient to induce robust IL-1 release (Taxman 2006). It is difficult to estimate actual 
MOI’s that occur during different stages of disease, however it is generally acknowledged 
that MOI increases during disease progression and that cytokine release occurs prior to cell 
death. The different times and dosages leading to cytokine induction vs. cell death suggests 
that cytokine release may be an early primary response, while cell death is a late response 
indicative of a higher bacteria load.  Our results further demonstrate that Pg induced cell 
death requires both ASC and NLRP3. S. flexneri also induces an ASC and NLRP3 dependent 
macrophage cell death (Willingham 2007).  Cell death induced by F. tularensis and by 
Salmonella, however, is ASC dependent but not NLRP3-dependent suggesting specificity of 
pathogen-NLR pairing in host response (Willingham 2007, Mariathasan 2006, Mariathasan 
2004). 
We have shown that Pg-induced cell death is caspase-independent.  This 
finding suggests that the cell death process does not involve the formation of a conventional 
IL-1 inflammasome. Caspase-1 is a core component of the inflammasome and is required 
for IL-1 activation (Martinon 2002). Therefore, different mechanisms may underlie 
cytokine activation and cell death. Further studies will be necessary to determine the nature 
of the protein complex regulating microbial pathogen induced death. 
Recently, Fernandes-Alnemri and coworkers reported that pro-inflammatory 
stimuli such as LPS and monosodium urate induce ASC speck formation in THP1 cells in a 
caspase-1 dependent manner (Fernandes-Alnemri 2007).  Others have described a type of 
caspase-1 dependent cell death termed pyroptosis in Salmonella infected macrophages that is 
characterized by cell swelling and osmotic lysis (Fink 2006). In contrast, the biochemical and 
morphological features of Pg induced cell death are consistent with pyronecrosis, a caspase-1 
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independent cell death pathway also activated by S. flexneri and Campylobacter jejuni 
(Willingham 2007, Siegesmund 2004).  However it should be noted that overexpression 
studies have associated ASC with apoptosis (McConnell 2000, Ohtsuka 2004) and F. 
tularensis induces apoptotic ASC-dependent macrophage death in mice (Mariathasan 2005). 
Thus, it is reasonable to hypothesize that pathogens can induce both apoptotic and non-
apoptotic host cell death, and ASC may serve a role in either type of cell death depending on 
the specific stimulation, the state of the cell, or other unknown factors.  
 
The two-step release of pro-inflammatory cytokine IL-1 has been proposed 
by several studies (Mariathasan 2007, Sutterwala 2006, Lich 2006). This occurs when 
macrophages are confronted with bacteria represents a synergistic activation of TLR and 
NLR signaling pathways. First, bacteria and/or their cellular components activate a 
TLR/MyD88 dependent NF-B signaling thereby making pro IL-1 available for release. 
The concurrent activation of the inflammasome via the NLR/ASC/caspase-1 axis then leads 
to cleavage and release of mature IL-1 to awaken the local immune response. TLRs are also 
critical for other cytokines such as TNF-, IL-6 and IL-8. Pathogen-induced 
monocytic/macrophage necrotic-like cell death may represent an alternative or added 
approach to activate the immune system. In addition to the release of amplified levels of 
proinflammatory cytokines, the release of cellular contents by monocytes and macrophages 
during necrosis may send out an amplified “host danger signal” to alert the immune system 
to invading microorganisms (Willingham 2007). From this standpoint, it would be strategic 
for immune cells at the site of bacterial invasion to undergo necrosis and to release 
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inflammatory mediators including cytokines and HMGB1 (El Mezayen 2007) to 
activate/recruit other inflammatory cells to aid in resolving an infection. On the other hand, 
necrotic cell death is also known to propagate and exacerbate an inflammatory response.  
Future studies using an in vivo mouse model of Pg challenge should provide insights on 
whether the disruption of this NLRP3-ASC axis can alter periodontal disease pathogenesis 
and disease outcome. 
  
Pg-induced cell death is accompanied by endogenous formation of ASC 
specks in monocytic cells following bacteria exposure, representing the first demonstration of 
endogenous ASC speck formation in response to a pathogen.  Though ASC has a well 
established role in cell death, far less is known about the protein complex that mediates 
ASC/NLRP3-dependent cell death or whether the ASC speck might represent a platform for 
formation of a death complex.  Since cell death and speck formation are ablated in ASC and 
NLRP3 knockdown cells (Figures 2 and 6A), NLRP3 appears to function in concert with 
ASC to cause death and speck formation.  
In summary, our data indicate that NLRP3 and ASC are central in Pg induced 
cell death and cytokine release. The necrotic-like nature of Pg induced cell death in 
monocytes/ macrophages may suggest a potential cellular host mechanism to combat 
infection. The critical roles of NLRP3 and ASC in macrophage cell death and ASC speck 
formation provides a first step in elucidating potential mechanisms of macrophage defense 
against Pg. The formation of ASC specks could serve as a novel molecular platform that 
fosters pathogen induced cell death. These findings and future studies should lead to a better 
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understanding of bacterial-induced periodontitis and could contribute to the design of better 
therapeutics. 
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2.5 Materials and Methods 
Cell culture and peripheral blood macrophage preparation                                        
THP1 cells (ATCC)
 
were cultured in RPMI 1640 with 10% characterized fetal bovine 
serum. Peripheral blood macrophages were isolated on buffy coats from healthy donors 
(American Red Cross). Primary macrophages were harvested by Ficoll-Hypaque 
gradients and seeded in 10 ml RPMI 1640 medium containing 10% heat-inactivated fetal 
bovine serum. Nonadherent cells were removed. Where indicated, cells
 
were treated for 
24-72 hours with Pg strain A7436, E. coli or S. typhi at the indicated multiplicity
 
of 
infection (MOI), with 0.1 - 1 µM staurosporine (Sigma-Aldrich St. Louis, MO), or with 
0.01 or 0.1
 
µg/ml Ultrapure Pg LPS (InvivoGen San Diego, CA). Pg LPS was purified 
from strain ATCC33277 (Coats 2003) according to the manufacture and would be 
expected to function as either a TLR2 and TLR4 agonist. (InvivoGen San Diego, CA). 
10µM BD ApoAlert VAD-fmk (pan-caspase inhibitor)
 
or YVAD-cmk (caspase-1 
inhibitor) (BD Clontech San Jose, CA), or 10µg/ml of the IL-1 receptor antagonist 
Anakinra (Kineret;
 
Amgen Boston, MA) was added 2 hours before Pg where indicated.  
Bacterial culture and viability assays      
Pg strains A7436 was cultured anaerobically and E. coli strain DH5 aerobically as 
previously described (Taxman 2006). Bacteria were collected by centrifugation and 
resuspended in broth containing 20% glycerol. Frozen aliquots were stored at -80 C. The 
MOI of the inoculum was confirmed by plating serial dilutions of Pg anaerobically on 
either blood agar or Wilkins- Chalgren (WC) agar, and E. coli aerobically on LB agar. 
Counts are accurate within 1.5 fold. For viability assays, THP1 cells (control, ASC and 
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NLRP3 knockdowns) were washed 3X and resuspended in antibotic free medium (RPMI 
1640 and 10% FBS). 10
6 
cells per ml were seeded and exposed to various MOI of Pg for 
24, 48 and 72 hours. After bacteria/cell interactions, total cultures (THP1 and Pg) were 
plated in serial dilution anaerobically in either blood agar or WC agar. Colony Forming 
Units (CFU) were counted and CFU per ml of total culture were calculated and 
estimated. At least 3 independent experiments were performed and a representative 
experiment is shown.  
 
Preparation of Sh-RNA plasmids and cell lines for ASC and NLRP3 knockdown  
Plasmids for expression of sh (short hairpin) RNAs were made by inserting a histone
 
H1 
promoter, Sh-RNA, and termination sequence into a GFP-containing
 
pHSPG retroviral 
shuttle vector as previously described (Willingham 2007, Taxman 2006). The Sh-RNA 
target
 
sequences are Sh-ASC#1-GCTCTTCAGTTTCACACCA; Sh-CNTRL-
GCTCTTCctggcCACACCA; Sh-ASC#2-CCTGGAACTGGACCTGCAA; Sh-NLRP3 
#1-GGATGAACCTGTTCCAAAA; and Sh-NLRP3 #2-AGATGGAGTTGCTGTTTGA. 
IFN response was not activated by Sh-RNA as
 
assessed by OAS1 expression (not 
shown). 
Real-time PCR analysis             
Preparation of RNA and cDNA was performed using RNeasy column purification and 
MMLV as previously described (Taxman 2006).  Real-time PCR experiments were 
performed using an AB Prism 7700 thermocycler (Applied Biosystems Foster City, CA) 
with 58°C annealing temperature. All values were normalized to 18s expression. Primer 
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used are as follows: ASC-FW: AACCCAAGCAAGATGCGGAAG; ASC-RV: 
TTAGGGCCTGGAGGAGCAAG; NLRP3-FW: ATGCCAGGAAGACAGCATTG; 
NLRP3-RV: TCATCGAAGCCGTCCATGAG, 18s-FW: CGGCTACCACATCCAAGG; 
18s-RV: GCTGCTGGCACCAGACTT. 
 
ELISA               
Supernatants were assessed 18–24 hours following stimulation using a human IL-1β 
ELISA set (BD Biosciences). Samples were assayed
 
within linear range. All values 
represent
 
averages + SD of experiments performed in triplicate. 
Cell death measurement 
Bacteria induced cell death in THP1 cells was assessed by incubation of cells with 
medium containing Hoechst 33342 (10 µM) and propidium iodide (PI) (20 µM) for 10 
minutes at 37
o
C. Results were visualized and imaged under a Zeiss fluorescent inverted 
microscope with a UV filter. Cell numbers (≥2000 cells per field) were quantified by 
using NIH Image J software. Cell death is represented as a percentage of PI postive cells 
(% PI positive cells = (PI positive cells / Hoechst 33342 positive cells) x 100). 
Quantification of Pg LPS treated cells required a less stringent setting of intensity in 
Image J to accurately estimate the % PI positive cells due to the clumping of cells upon 
Pg LPS treatment. Results represent the average total of experiments performed in 
triplicate. 
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ASC Western analysis 
Cell lysates of Sh-CNTRL and Sh-ASC were prepared as described previously (Taxman 
2006). Immunoblots for ASC and GAPDH were performed using anti-ASC antibody 
(Axxora Inc. San Diego, CA) and anti GAPDH antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA). All results are representative of three independent
 
experiments. 
 
PARP cleavage assays 
Cell lysates were prepared as described previously (Willingham 2007, Taxman 2006). 
Immunoblots for PARP were performed using anti-PARP antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA). All results are representative of three independent
 
experiments. 
 
Transmission electron microscopy 
Routine transmission electron microscopy was carried out as described previously 
(Willingham 2007). For immunoelectron microscopy, cells were fixed in suspension with 
4% paraformaldehyde/0.15% glutaraldehyde/0.15M sodium phosphate for 1 hour at room 
temperature.  The cells were stained using an immunogold-silver protocol (Yi 2001). A 
1:250 dilution was used for the primary antibody (rabbit anti-ASC; Axxora San Diego, 
CA) and a 1:100 dilution for the secondary antibody (donkey anti-rabbit IgG 0.8nm 
immunogold (Aurion Netherlands, Electron Microscopy Sciences Hatfield, PA). 70nm 
sections were cut, mounted on nickel grids, silver enhanced for 30 minutes, and stained 
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with Reynolds’ lead citrate.  Samples were observed using a LEO EM910 transmission 
electron microscope operating at 80kV (LEO Electron Microscopy Inc., Thornwood, 
NY).  Digital images were acquired using a Gatan Orius SC1000 CCD Digital Camera 
and Digital Micrograph 3.11.0 (Gatan, Inc., Pleasanton, CA). 
 
ASC aggregation speck visualization and quantification 
Prior to immunofluorescent staining THP1 cells or primary peripheral blood 
macrophages were washed 3x in PBS and fixed in 100% methanol.  Rabbit anti-human 
ASC (Axxora) was used to stain for endogenous ASC.   Anti-rabbit Alexa Fluor 488 
(Molecular Probes Carlsbad, CA) was used as a secondary antibody. Background staining 
was controlled by staining cells using an isotype control antibody. Visualization of 
endogenous ASC was performed on a Zeiss LSM5 PASCAL confocal microscope. ASC 
specks were quantified as follows: the number of speck containing cells was divided by 
total number of cells x 100 per field.  At least 10 fields of ≥150 cells were blindly 
selected and counted per experiment and average and standard deviation were calculated. 
 
Overexpression of NLRP3 and disease associated NLRP3 mutant R260W in THP1 cells 
Adenovirus encoding NLRP3 WT and a disease associated mutant R260W were 
transduced in THP1 cells at an MOI of 1 as previously described (Willingham 2007). 
Cells were assayed 9 hours post transduction. 
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Figure 2.1: Pg induced cell death is ASC-dependent in THP1 monocytic cells. 
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Figure 2.1 Pg induced cell death is ASC-dependent in THP1 monocytic cells. 
(A) Visualization of Pg-induced cell death by PI staining.  THP1 cells were exposed to 
Pg at MOI of 0, 100, or 300 for 72 hours and stained with Hoechst 33342 (blue) and PI 
(red). Hoechst stains all cells, while PI stains cells that lose membrane integrity while 
undergoing cell death. At least three independent experiments were performed. Each 
experiment was comprised of triplicate wells per dose of Pg exposure. An image was 
taken per well and a representative image is shown.  
(B) Quantification of PI staining following a timecourse of Pg infection.  THP1 cells 
were exposed to Pg at the indicated MOI for 24, 48 or 72 hours. Cell death was evaluated 
by PI exclusion and quantified as % PI positive using Image J computer software to count 
cells. Error bars indicate standard deviation of the mean for three independent 
experiments performed in triplicate. *, p < 0.05 when compared to untreated controls. 
(C) Reduced ASC expression in ASC knockdown THP1 cells.  ASC expression in Sh-
ASC cells was measured by real-time PCR and was compared to expression in THP1 
cells stably transfected with a specific control vector (Sh-CNTRL). Results represent 
average plus standard deviation for triplicate samples. 
(D) Reduced ASC expression in ASC knockdown THP1 cells.  ASC expression in Sh-
ASC cells was measured by Western analysis and was compared to expression in THP1 
cells stably transfected with a specific control vector (Sh-CNTRL). GAPDH is shown as 
a loading control. Results are representative of three independent experiments. 
(E) THP1 cells bearing an ASC Sh-RNA knockdown (Sh-ASC) or a control Sh-RNA 
containing a scrambled target site (Sh-CNTRL) were exposed to Pg for 72 hours at the 
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indicated MOI. Cell death was visualized by PI exclusion assay as described above. At 
least three independent experiments were performed in triplicate. An image was taken for 
each well per dose and a representative image is shown. 
(F) Sh-CNTRL and Sh-ASC cells were treated with Pg at MOI of 0-1200 for 72 hours.  
Cells were stained with PI following 72 hours exposure to Pg and % PI positive cells 
were quantified using Image J. Error bars indicate standard deviation of the mean for 
three independent experiments performed in triplicate. *, p < 0.05 when compared to Sh-
CNTRL with respective Pg dose exposure.  
(G) THP1 cells were exposed to Pg at MOI of 300. Pg was recovered after 0, 24, 48 and 
72 hours post bacterial exposure from THP1 culture by plating by serial dilution and CFU 
per ml was calculated. At least three independent experiments were performed in 
triplicate. A representative experiment is shown. Error bars indicate standard deviation of 
the mean of triplicate wells.  
(H) THP1, Sh-CNTRL, Sh-ASC #1 and Sh-NLRP3 #1 were exposed to Pg at MOI of 
300. Pg was recovered 72 hours post bacterial exposure from THP1 culture by plating by 
serial dilution and CFU per ml was calculated. At least three independent experiments 
were performed in triplicate. A representative experiment is shown. Error bars indicate 
standard deviation of the mean of triplicate wells.  
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Figure 2.2: Pg induces NLRP3-dependent cell death.  
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Figure 2.2 Pg induces NLRP3-dependent cell death.  
(A) Reduced NLRP3 expression in NLRP3 knockdown THP1 cells.  NLRP3 expression 
in Sh-NLRP3 cells was measured by real-time PCR and was compared to expression in 
non-transfected THP1 cells (THP1) and THP1 cells stably transfected with an empty 
vector (7) or Sh-RNA against ASC (Sh-ASC #1).  
(B) Reduced IL-1 induction in NLRP3 knockdown cells. Cells were exposed to Pg at an 
MOI of 50 for 24 hours and secreted IL-1 was measured by ELISA.  Reduced IL-1β 
induction is shown for two ASC knockdown THP1 cell lines (Sh-ASC #1 and Sh-ASC 
#2), as well as two NLRP3 knockdown lines (Sh-NLRP3 #1 and Sh-NLRP3 #2).  IL-1 
induction in THP1 cells, THP1 cells expressing an empty vector (7), and THP1 cells 
expressing Sh-RNA with a scrambled target (Sh-CNTRL) were assayed as a control. 
Error bars indicate standard deviation of the mean for three independent experiments 
performed in triplicate. *, p < 0.05 when compared to Sh-CNTRL treated with Pg. 
(C) Induction of cell death in control and Sh-NLRP3 cells.  Control empty vector  (black 
bars) and Sh-NLRP3 knockdown cells (gray bars) were exposed to Pg for 72 hours at the 
indicated MOI. Cell death was evaluated by PI exclusion assay and quantified using 
Image J. Error bars indicate standard deviation of the mean for three independent 
experiments performed in triplicate. *, p < 0.05 when compared to EV with respective Pg 
dose exposure. 
(D) Cell death induction for a panel of control and Sh-RNA knockdown cell lines. Cell 
death was measured for control lines THP1, EV, and Sh-CNTRL; for ASC knockdown 
lines, Sh-ASC #1 and Sh-ASC #2; and for NLRP3 knockdown lines, Sh-NLRP3 #1 and 
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Sh-NLRP3 #2.  Cell lines were exposed to Pg at an MOI of 300 for 72 hours prior to PI 
staining and quantification by Image J. Error bars indicate standard deviation of the mean 
for three independent experiments performed in triplicate. *, p < 0.05 when compared to 
Sh-CNTRL treated with Pg. 
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Figure 2.3: Bacteria induced cell death is strain specific. 
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Figure 2.3 Bacteria induced cell death is strain specific. 
(A) Induction of cell death by Pg LPS is ASC-dependent. Sh-CNTRL and Sh-ASC cells 
were left untreated or were treated with 0.01 or 0.1 g/ml Pg LPS for 24 hours. Cell 
death was evaluated by PI exclusion assay. At least three independent experiments were 
performed in triplicate. An image was taken for each well per dose and a representative 
image is shown. 
(B) Sh-CNTRL, Sh-ASC and Sh-NLRP3 cells were treated with 0, 0.01, or 0.1g/ml Pg 
LPS for 24 hours. Cell death was evaluated by PI exclusion assay and quantified by 
Image J software. Results are the average plus standard deviation of three independent 
experiments performed in triplicate wells. 
(C) Induction of cell death in ASC and NLRP3 knockdown cells following infection with 
E. coli.  EV, Sh-ASC and Sh-NLRP3 cells were exposed to E. coli at an MOI of 5 and 10 
for 24 hours and cell death was evaluated using PI exclusion assay and quantified using 
Image J. Error bars indicate standard deviation of the mean for three independent 
experiments. *, p < 0.05 when compared to Sh-CNTRL with respective E. coli dose 
exposure. 
(D) Salmonella typhi induces an ASC dependent but NLRP3 independent cell death. 
THP1 cells Sh-CNTRL, Sh-ASC and Sh-NLRP3 were treated with Salmonella typhi for 1 
hour at a MOI of 50. Cell death was evaluated using PI exclusion assay and quantified 
using Image J. Error bars indicate standard deviation of the mean for three independent 
experiments. *, p < 0.05 when compared to Sh-CNTRL with respective Salmonella typhi 
dose exposure. 
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Figure 2.4: Pg induces necrotic-like cell death. 
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Figure 2.4 Pg induces necrotic-like cell death. (A) Characterization of Pg-induced cell 
death by Transmission Electron Microscopy (TEM).  TEM was performed on THP1 cells 
with an empty vector (7) that were left untreated (i) or treated with 0.5µM of 
staurosporine (22), on Pg-infected THP1 cells bearing a scrambled Sh-RNA target (Sh-
CNTRL) (iii) and on Pg-infected THP1 cells were bearing Sh-RNA against ASC (Sh-
ASC) (26).  Pg infections were at an MOI of 100 for 72 hours. Two experiments were 
performed. Each experiment was comprised of duplicate wells per condition. At least 50 
images were taken per condition and a representative image is shown.  
(B) Pg-induced cell death is caspase and IL-1-independent. Cells were treated with Pg at 
an MOI of 300 for 48 hours. Sh-CNTRL cells were pre-treated with 10 µM of pan-
caspase inhibitor (Z-VAD), caspase-1-specific inhibitor (Y-VAD) or 10 µg/ml of the IL-
1R antagonist, Kineret 1 hour prior to infection.  Sh-ASC cells were infected with Pg in 
parallel. Cell death was evaluated using PI exclusion assay and quantified using Image J. 
Error bars indicate standard deviation of the mean for three independent experiments 
performed in triplicate. *, p < 0.05 when compared to Sh-CNTRL with or without 
inhibitors exposed to Pg. 
(C) Stauroporine-induced cell death is not ASC or NLRP3-dependent. THP1 cells with 
EV, Sh-ASC or Sh-NLRP3 were treated with 0.5µM of staurosporine for 24 hours. Cell 
death was evaluated using PI exclusion assay and quantified using Image J. Error bars 
indicate standard deviation of the mean for three independent experiments performed in 
triplicate. 
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(D) Staurosporine-induced PARP cleavage is not ASC-dependent. THP1 cells with EV or 
Sh-ASC were treated with 0, 0.1, 0.5 and 1 µM of staurosporine for 24 hours and PARP 
cleavage was evaluated by Western blotting. At least three independent experiments were 
performed. An image of a representative Western blotting experiment is shown.   
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Figure 2.5: Pg induces ASC aggregation speck formation in THP1 cells.  
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Figure 2.5 Endogenous characterization of ASC aggregation speck in THP1 cells. (A) (i) 
Control, untreated THP1 cells stained with rabbit isotype control antibody and secondary 
fluorochrome only, (22) untreated control cells stained with antibody against ASC and 
secondary fluorochrome, (iii) THP1 cells exposed to Pg at an MOI of 300 for 24 hours 
followed by staining with antibody against ASC and secondary fluorochrome. Cells were 
visualized by fluorescent microscopy using a 20X magnification lens.  
(B) 60X magnification of ASC speck formation in Pg-induced THP1 cells.  Specks were 
visualized with a fluorescence filter (FITC) or differential interference contrast (DIC). A 
merged field is also shown. At least three independent experiments were performed per 
condition. At least 10 images were taken per condition and representative images are 
shown. 
(C) THP1 cells exposed to Pg at an MOI of 300 for 24 hours followed by staining with 
TEM Immunogold using an antibody against ASC. The position of the ASC speck is 
shown relative to the nucleus.   
(D) TEM Immunogold image showing an engulfed bacteria. 
Two independent experiments were performed in duplicate per condition. At least 50 
images were taken per condition and representative images are shown. 
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Figure 2.6: Pg-induced ASC aggregation speck formation is NLRP3 dependent. 
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Figure 2.6 Pg-induced ASC aggregation speck formation is NLRP3 dependent. 
(A) Speck formation requires both ASC and NLRP3.  THP1 cells with EV, Sh-ASC and 
Sh-NLRP3 were exposed to Pg at an MOI of 100 for 24 hours and stained for ASC 
specks. Cells were visualized using fluorescent microscopy and the percent of cells 
containing ASC aggregation specks upon exposure to Pg was quantified. Error bars 
indicate standard deviation of the mean for three independent experiments performed in 
triplicate. *, p < 0.05 when compared to untreated empty vector controls; **, p < 0.05 
when compared to Pg treated empty vector controls.  
(B) A disease-associated NLRP3 mutant induces speck formation.  THP1 cells were 
transduced with adenovirus encoding a wild type NLRP3 gene or an NLRP3 disease-
associated mutant, R260W, or were exposed to Pg at an MOI of 100 for 24 hours. ASC 
specks were visualized by immunostaining and fluorescent microscopy and were 
quantified as in Figure 6A. Error bars indicate standard deviation of the mean for three 
independent experiments performed in triplicate. *, p < 0.05 for mut NLRP3 when 
compared to cells treated with wild type NLRP3 gene. 
 
 
 
 
 
64 
 
Figure 2.7: Pg induces cell death and ASC aggregation specks in human peripheral 
blood macrophages.  
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Figure 2.7 Pg induces cell death and ASC aggregation specks in human peripheral blood 
macrophages. (A) Cell death induction in human peripheral blood macrophages 
following Pg treatment. Human peripheral blood macrophages were exposed to Pg at an 
MOI of 0, 100 or 300 for 24, 48 or 72 hours as indicated. Cell death was evaluated using 
the PI exclusion assay and quantified using Image J. Error bars indicate standard 
deviation of the mean for three independent experiments performed in triplicate. *, p < 
0.05 when compared to untreated controls. 
(B) Speck formation in human peripheral blood macrophages. Human peripheral blood 
macrophages exposed to Pg at an MOI of 100 for 24 hours were stained for ASC and 
specks were visualized using confocal microscopy (FITC).  An image of the cells 
visualized by differential interference contrast (DIC) is also shown, as well as merged 
fields. Three independent experiments were performed. At least 10 images were taken per 
experiment and representative images are shown. 
(C) Quantification of specks in human peripheral blood macrophages. Human peripheral 
blood macrophages exposed to Pg at MOIs of 0 – 300 for 24 hours were stained for ASC 
and the percent of cells containing ASC aggregation specks was quantified as in Figure 6. 
Error bars indicate standard deviation of the mean for three independent experiments 
performed in triplicate. *, p < 0.05 when compared to untreated control.
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3.1 Abstract 
Francisella tularensis is a facultative intracellular pathogen and potential 
biothreat agent. Evasion of the immune response contributes to the extraordinary virulence of 
this organism although the mechanism is unclear.  While wild type strains induced little 
cytokines, an F. tularensis ripA deletion mutant (LVSΔripA) provoked significant release of IL-
1β, IL-18 and TNF-α by macrophages. IL-1β and IL-18 secretion was dependent on 
inflammasome components PYCARD/ASC and Caspase-1, while the TLR/IL-1R signaling 
molecule, MyD88, was required for inflammatory cytokine synthesis. Complementation of 
LVSΔripA with a plasmid encoding ripA restored immune evasion. Similar findings were 
observed in a human monocytic line. The presence of ripA nearly eliminated activation of MAP 
kinases including ERK1/2, JNK and p38 while pharmacologic inhibitors of these three MAPKs 
reduced cytokine induction by LVSΔripA. Animals infected with LVSΔripA mounted a stronger 
IL-1β and TNF-α response than mice infected with LVS. This analysis revealed novel immune 
evasive mechanisms of F. tularensis.     
 
3.2 Introduction 
Francisella tularensis is a Gram-negative facultative intracellular pathogen that is 
the causative agent of the zoonotic disease tularemia. The organism can be transmitted to a host 
through insect bites, handling of infected carcasses, and inhalation of aerosolized bacteria (Keim 
et al., 2007; Oyston et al., 2004). F. tularensis is a potential agent of biological warfare classified 
as a Category A select agent by Center for Disease Control (CDC) due to its highly infectious 
nature; roughly 50% mortality with an infectious dose of as few as 10 bacteria via inhalation 
(Rotz et al., 2002). During the cold war, both the former Soviet Union and the United States of 
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America weaponized and stockpiled F. tularensis in their biological weapons programs (Pechous 
et al., 2009). The World Health Organization (WHO) has estimated that a 50 kilogram release of 
F. tularensis over a 5 million metropolis would cause 250,000 incapacitating casualties and 
19,000 deaths (WHO 1970). The CDC also estimated that a F. tularensis attack would cost 5.4 
billion to the society for every 100,000 infected individuals (Kaufmann et al., 1997). Four 
subspecies of F. tularensis exist including tularensis, holarctica, mediasatica and novacida 
(Sjostedt, 2006). The most virulent strain for humans is the subspecies tularensis which is found 
primarily in North America. Subspecies holarctica is less virulent and was used to generate a 
live vaccine strain (LVS). LVS is attenuated in humans but remains highly virulent for mice and 
thus is extremely useful as a model to study F. tularensis pathogenesis.  
Since exposure to the respiratory tract results in the most aggressive form of 
tularemia, several laboratories developed mouse models of pulmonary tularemia to study this 
mode of infection (Chiavolini et al., 2008; Hall et al., 2008). Using an intranasal delivery model, 
the median lethal dose (LD50) of LVS is 10
3 
CFU (Hall et al., 2008). By comparison the LD100 
for the highly virulent F. tularensis subspecies tularensis strain SchuS4 is less than 20 CFU 
(Kirimanjeswara et al., 2008). Upon inhalation, the bacteria are restricted to the lung for 
approximately 36 to 48 hours where the organism persists and multiplies (Fuller et al., 2008). 
During this time, little host immune response occurs as evidenced by the lack of pro-
inflammatory cytokines IL-1β, TNF-α, IL-6 and IFN-γ (Chase et al., 2009). 2-4 days post 
infection, inflammatory cells infiltrate the lung and pro-inflammatory cytokines can be detected 
in vivo. By this time bacteria have overwhelmed the lung and disseminated to other organs such 
as spleen and liver. Mice eventually succumb to infection 5-7 days post inoculation. How F. 
tularensis circumvents the host immune response is not well understood. 
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F. tularensis is found in vivo within alveolar macrophages, dendritic cells (DC) 
and lung epithelial cells (Hall et al., 2008). Following entry into host cells, F. tularensis escapes 
the phagosome and enters the cytosol where it replicates. This process is apparently unhindered 
by innate immune defenses that typically detect and facilitate a response to eliminate foreign 
microbes. IFN-γ, TNF-α and IL-1β are critical mediators of an effective defense against 
Francisella infection (Mariathasan et al., 2005; Metzger et al., 2007). SchuS4 suppresses pro-
inflammatory cytokine induction in mouse lung resident DCs in early stages of the disease 
(Chase et al., 2009). Similarly, LVS dampens intracellular signaling and TNF-α in human 
monocytes and mouse macrophages (Telepnev et al., 2003). Administration of anti-IFN-γ, and 
anti-TNF-α antibodies greatly reduces the LD50 of LVS in an intradermal mouse model of mouse 
tularemia (Leiby et al., 1992). IL-1β also is critical in innate defense against F. tularensis 
subspecies novicida (Mariathasan et al., 2005). Disrupting the signaling pathway that leads to IL-
1β processing greatly enhances host susceptibility to F. novicida infection.  
  IL-1β, one of the more potent pro-inflammatory cytokines, is tightly regulated by 
a two-step signaling process. The first step requires the transcriptional activation of pro-IL-1β 
followed by the translation of the pro-protein.  This is achieved by engagement of the toll-like 
receptors (TLR) and subsequent activation of MyD88-dependent signaling pathways, leading to 
NF-κB and MAP kinase induction. This leads to translocation of the NF-κB subunit p65 from the 
cytosol to the nucleus and activation of the MAP kinase phosphorylation cascade to cause the 
transcription of pro-IL-1β message. A second and separate signal is required after pro-IL-1β 
protein is produced, and this occurs in the cytosol, leading to the assembly of an inflammasome 
complex.  There are several types of inflammasomes, including those which contain an NLR 
(nucleotide binding domain-leucine rich repeats containing) component, and those which contain 
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a non-NLR component, such as AIM2 (absent in melanoma 2) or RIG-I (retinoic acid-inducible 
gene 2) (Fernandes-Alnemri et al., 2009; Hornung et al., 2009; Poeck et al., 2009). Procaspase-1 
is a requisite member of the complex, while the adaptor PYCARD/ASC/TMS1 (Pyrin-CARD, 
apoptotic speck-containing protein with a CARD, or target of methylation-induced silencing) is 
found in most inflammasome complexes (Conway et al., 2000; Masumoto et al., 1999).  Upon 
inflammasome formation, procaspase-1 undergoes auto-catalytic cleavage into an active, mature 
form which subsequently cleaves pro-IL-1β and pro-IL-18 into their active forms. 
NLR family members share a conserved structure, with most of the members 
bearing an N-terminal Pyrin or CARD (caspase recruitment domain) domain followed by an 
NBD domain; and a C-terminal LRR domain that is homologous to those found in TLRs (Ting 
and Davis, 2005). A current working hypothesis is that, upon induction, the NLR recruits 
PYCARD via a Pyrin-Pyrin homo-typic interaction. PYCARD possesses its own CARD domain 
which recruits Caspase-1 into the inflammasome complex for IL-1β processing. Several NLRs 
that contribute to pathogen induced IL-1β release in macrophages have been identified (Pedra et 
al., 2009). The absence of NLRs or their adaptors renders hosts more susceptible to a variety of 
pathogens. The NLRP3 inflammasome senses a wide variety of intracellular pathogens including 
Gram-positive and Gram-negative bacteria, RNA viruses, DNA viruses, yeast, microbial toxins 
and a host of damage-associated molecular patterns such as silica, asbestos and alum (Schroder 
and Tschopp). The NLRC4/Ipaf inflammasome respond to bacterial virulence factors from the 
type III and IV secretion systems from bacteria such as Salmonella typhi, Burkholderia 
pseudomalle, Escherichia coli (Abdul-Sater et al., 2009; Miao and Warren, ; Sutterwala et al., 
2007) and Pseudomonas aeruginosa (Mariathasan et al., 2004).  
71 
 
Unlike most Gram-negative bacterial pathogens, F. tularensis subspecies 
tularensis and holarctica do not provoke a substantial initial inflammatory response in vitro or in 
vivo (Bosio et al., 2007; Chase et al., 2009; Cole et al., 2006).  F. tularensis LPS does not 
stimulate significant signaling through TLR4 (Abplanalp et al., 2009), but this property alone 
does not account for the muted host response to infection.  The goal of this study was to identify 
mechanisms by which F. tularensis actively suppresses the host innate immune response.  To 
achieve this goal we used an attenuated F. tularensis mutant that elicited a robust inflammatory 
response to reveal signaling pathways that are normally suppressed by wild type organisms and 
which dampen IL-1β, IL-18 and TNF-α responses to infection. 
 
3.3 Results 
 
F. tularensis LVSΔripA fails to suppress the release of pro-inflammatory cytokines IL-1β, IL-
18 and TNF-α by mouse primary macrophages 
In response to foreign microbes, macrophages secrete pro-inflammatory cytokines 
including IL-1β, IL-18 and TNF-α which activate neutrophils, fibroblasts and endothelial cells to 
mount an anti-microbial response. F. tularensis can actively down-regulate host immune 
cytokine production in vivo and in vitro (Metzger et al., 2007; Sjostedt, 2006). To assess the 
ability of F. tularensis to induce cytokines, we first compared the induction profile for the pro-
inflammatory cytokine IL-1β in response to various bacterial pathogens in macrophages. We 
selected IL-1β due to its central role in initiating a variety of host immune defense cascades 
(Dinarello, 2009). When compared to Salmonella typhi, Klebsiella pneumonia and Shigella 
flexneri, mouse primary macrophages exposed to F. tularensis LVS released significantly less 
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IL-1β (Figure 1A) suggesting that F. tularensis LVS actively represses this particular 
inflammatory response. 
RipA (required for intracellular proliferation, factor A; FTL_1914) is a 
cytoplasmic membrane protein that is conserved among Francisella species and is required for 
adaptation of the bacteria to the host cell cytoplasm. Mutants lacking ripA (ΔripA strains) enter 
macrophages and escape from the phagosome at the same frequency and kinetics as wild type F. 
tularensis but fail to replicate within the host cell (Fuller et al., 2008). We considered that ΔripA 
strains might also be affected in their ability to suppress host cell immune responses. To test this 
possibility, we monitored IL-1β release by macrophages infected with wild type or LVSΔripA 
strains. Over a range of MOI, LVSΔripA induced, roughly 5-10 fold higher levels of IL-1β, than 
wild type infected macrophages (Figure 1B). Suppression of IL-1β was restored to LVSΔripA by 
in trans complementation with a ripA containing construct, pripA (Figure 1B), demonstrating a 
direct but inverse cause-and-effect relationship between F. tularensis RipA expression and IL-1β 
response. 
We next asked whether the effect of RipA on cytokine expression was widespread 
or limited to IL-1β. IL-18 production was measured since the inflammasome is also involved in 
processing and release of this cytokine. A similarly increased induction of IL-18 released by the 
LVSΔripA stimulated macrophages was observed and complementation reduced induction nearly 
to wild type levels (Figure 1C). Since F. tularensis induced TNF-α is not regulated by 
inflammasome components (Mariathasan et al., 2005) but is regulated by MyD88 (Abplanalp et 
al., 2009), we sought to test whether these findings hold true for LVSΔripA induced TNF-α 
release. LVSΔripA induced 2-3 fold more TNF-α than wild type LVS (Figure 1D). The 
magnitude of the difference between LVS and LVSΔripA induced TNF-α release by 
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macrophages was less than that of IL-1β. This suggests that ripA affects F. tularensis 
suppression of both inflammasome and non-inflammasome cytokines, but that the impact on 
inflammasome cytokines is more significant. Neither paraformaldehyde (PFA) fixed wild type 
nor LVSΔripA mutant strains provoked significant levels of IL-1β (Figure 1E) demonstrating 
that the observed impact of RipA on cytokine expression was not due simply to lack of 
intracellular replication by the deletion mutant strain. 
 
LVSΔripA induced-IL-1β is PYCARD, Caspase-1 and MyD88 dependent. 
In the regulation of IL-1β release by macrophages, bacterial derived pathogen- or 
microbe-associated molecular patterns (PAMPs or MAMPs) first activate the TLR signaling 
pathway thereby promoting the synthesis of pro-IL-1β transcript and later protein. A second 
signal initiates assembly of the inflammasome to process pro-IL-1β into IL-1β for release. To 
determine the level at which IL-1β release is regulated upon infection we tested whether 
disruption of either TLR or NLR/inflammasome signaling pathways can abrogate LVSΔripA 
induced IL-1β release. MyD88 was chosen for TLR signaling due to its central role in TLR/IL-
1R pathways. To disrupt inflammasome formation, mice deficient in either Pycard or Caspase-1 
were used since these two gene products are critical in F. novicida induced IL-1β release by 
mouse macrophages and the ulceroglandular form of tularemia (Mariathasan et al., 2005). 
Furthermore, two commonly interacting NLRs, NLRP3 and NLRC4 were tested because they are 
critical in the detection and response to several pathogens (Pedra et al., 2009). In the absence of 
Pycard, Caspase-1 and MyD88, macrophages did not release IL-1β upon LVS or LVSΔripA 
exposure (Figure 2A). However, absence of Nlpr3 or Nlrc4 did not impair the LVSΔripA 
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induced release of IL-1β suggesting that these NLRs are not involved in the sensing of F. 
tularensis. 
Similar to IL-1β release, PYCARD, Caspase-1, and MyD88 but not NLRP3 or 
NLRC4 were required for LVSΔripA induced IL-18 release by macrophages, further confirming 
effects on an additional inflammasome cytokine (Figure 2B).  As expected, MyD88 but not 
PYCARD, Caspase-1, NLRP3 or NLRC4 is required for LVSΔripA induced release of the non-
inflammasome cytokine TNF-α by primary mouse macrophages (Figure 2C). Taken together, 
LVSΔripA induced IL-1β production is mediated by PYCARD, Caspase-1 and MyD88 which 
suggests that F. tularensis LVS may target the PYCARD/Caspase-1 axis as well as other TLR-
dependent signaling pathways to suppress IL-1β release by macrophages. 
 
F. tularensis LVSΔripA fails to suppress pro-inflammatory cytokine response by human 
monocytic THP-1 cells. 
To determine if effects are also applicable to human cells, we measured cytokine 
expression by the human monocytic cell line, THP-1, in response to wild type LVS and 
LVSΔripA. THP-1 cells exposed to LVS∆ripA released 10-fold more IL-1β (Figure 3A) and 2-3 
fold more TNF-α (Figure 3B) than cells exposed to wild type LVS, which is consistent with the 
mouse primary macrophage response. Also consistent, the difference in amount of TNF-α 
induced between LVS and LVSΔripA is of smaller magnitude than that of IL-1β. 
We next investigated whether PYCARD/ASC was required for LVS∆ripA 
induced IL-1β release by THP-1 cells using cells stably expressing either a control scramble 
PYCARD retroviral ShRNA vector (Sh-Ctrl) that does not confer knockdown, a specific 
PYCARD retroviral ShRNA vector (Sh-PYCARD) to knock down PYCARD, or a specific 
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NLRP3 retroviral ShRNA vector (Sh-NLRP3) to knock down NLRP3 (Taxman et al., 2006). 
Cells were infected with LVS and LVS∆ripA, and IL-1β was monitored. 24 hours post infection, 
Sh-PYCARD-bearing THP-1 cells treated with either LVS or LVS∆ripA did not release 
detectable IL-1β (Figure 3C). In contrast, induction of IL-1β release was similar in sh-NLRP3-
bearing cells and Sh-Ctrl-bearing cells. This is consistent with our studies using gene-deficient 
mouse primary macrophages. To determine whether Caspase-1 is required for LVS∆ripA 
induced IL-1β release by THP-1 cells, THP-1 cells were pretreated with a specific Caspase-1 
inhibitor (10 μM Y-VAD-fmk). Porphyromonas gingivalis, which induces a Caspase-
1dependent IL-1β release in THP-1 cells (Huang et al., 2009), served as control. Y-VAD blocked 
IL-1β release in response to infection with P. gingivalis, and also with LVS and LVSΔripA 
(Figure 3D). Based on this data, we concluded that PYCARD and Caspase-1 are required in 
LVSΔripA induced IL-1β release by human monocytic THP-1 cells. 
 
F. tularensis LVSΔripA fails to suppress the processing and synthesis of IL-1β 
To elucidate the mechanisms by which F. tularensis suppresses host macrophage 
release of pro-inflammatory cytokines, we first sought to determine kinetics of intracellular IL-
1β synthesis and processing using western blot analysis to detect pro-IL-1β (33KD) and IL-1β 
(17KD) present in LVSΔripA infected mouse macrophages over a time course following 
inoculation. Pro-IL-1β levels increased starting at 30 minutes post LVSΔripA exposure (Figure 
4A), a time corresponding with the kinetics of phagosome escape by both wild type F. tularensis 
and LVSΔripA (Fuller et al., 2008). IL-1β processing occurred 30-45 minutes post infection and 
processed IL-1β accumulated over several hours (Figure 4A). By 24 hours post infection, the 
intracellular level of processed IL-1β decreased, likely due to release of IL-1β into the 
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extracellular space and death of macrophages. To determine whether the response to LVS and 
LVSΔripA differs in the synthesis and processing of IL-1β by macrophages, we repeated a time 
course of infection. By 60 minutes, LVS induced the synthesis of pro-IL-1β and no processed IL-
1β was evident. Pro-IL-1β increased significantly 120 minutes post-inoculation with LVS; 
however only a small fraction of the pro-protein was processed to mature IL-1β at this point 
(Figure 4B, 4C). In contrast, pro-IL-1β was present in LVSΔripA infected macrophages by 60 
minutes post infection, with the majority processed to mature IL-1β. Pro- IL-1β continued to 
increase by 120 minutes post-inoculation, with half of the pro-protein processed to mature IL-1β. 
Next, we sought to determine if F. tularensis LVS also disrupted of the synthesis 
of pro- IL-1β. To accomplish this objective, we exposed Pycard-/- mouse primary macrophages 
to LVS and LVSΔripA and monitored the synthesis of pro-IL-1β. Since the absence of PYCARD 
abolishes the processing of pro-IL1β into mature IL-1β, we can directly compare the macrophage 
synthesis of pro-IL1β. In the absence of IL-1β processing, LVSΔripA infected macrophages 
induced significantly more pro-IL-1β than LVS (Figure 4D, 4E). Thus, F. tularensis LVS 
disrupts both the synthesis and processing of pro-IL-1β by macrophages. Collectively, these data 
suggest that the removal of RipA affected signaling pathways required for both the synthesis and 
processing of pro-IL-1β. 
The effect of RipA on both pro- IL-1β and TNF-α synthesis led us to test the 
effect of RipA on pathways that can affect the production of both cytokines. Since NF-κB is a 
master transcriptional regulator that controls a wide range of host immune responses, including 
cytokine production, we sought to determine if F. tularensis LVS interfered with NF-κB 
signaling in macrophages. Degradation of IκBα and phosphorylation of p65 were monitored 
because both events are involved in NF-κB activation. Degradation of IκBα allows 
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phosphorylation and translocation of p65 into nucleus which subsequently binds to promoters of 
pro-inflammatory genes. LVS and LVSΔripA each induced degradation of IκBα 30-60 minutes 
post infection, and phosphorylation of p-65 15-30 minutes post infection (Figure 4F). LVSΔripA 
appeared to induce slightly faster degradation of IκBα and phosphorylation of p65; however, 
these small differences alone are unlikely to account for the significant differences between 
LVSΔripA and LVS in the induction of TNF-α and pro-IL-1β.  
 
F. tularensis LVSΔripA fails to dampen the activation of MAP kinase pathways 
Another common group of signaling pathways that contributes to cytokine 
activation by bacteria and bacterial components are the MAP kinase pathways. F. tularensis LVS 
initially activates MAP kinase signaling pathways but subsequently down-regulates their activity 
(Telepnev et al., 2005). To determine whether the difference between the cytokine activation by 
LVS and LVSΔripA might be explained by differences in the induction of MAP kinases, we 
profiled the phosphorylation of ERK1/2, JNK and p38 in macrophages following infection. LVS 
induced modest levels of ERK1/2 and p38 phosphorylation which peaked at 30 and 60 minutes, 
but induced very little JNK activation (Figure 5A). In contrast, LVSΔripA induced dramatic 
levels of ERK1/2 phosphorylation at 15-30 minutes, and of JNK and p38 at 30-60 minutes post 
inoculation. These data suggest that LVS dampened the induction of MAP kinase signaling 
pathways by a mechanism that is missing or ineffective in the ΔripA mutant strain. 
To determine whether differences in MAP kinase activation might explain the 
increased inflammatory nature of LVSΔripA, we abrogated MAP kinase activity in ΔripA 
infected cells with pharmacological inhibitors of ERK, JNK and p38 signaling pathways. 
Primary mouse macrophages were treated with U0126, SP-600125 or SB-202190 to prevent the 
78 
 
phosphorylation of ERK1/2, JNK and p38, respectively. These cells were subsequently exposed 
to either LVS or LVSΔripA and IL-1β release was measured 24 hours post infection. Both 
U0126 and SP-600125 reduced the release of IL-1β by macrophages by 1.5-2 fold following 
infection with LVSΔripA over a range of doses (Figure 5B). Thus, both the ERK and JNK 
pathways contribute to IL-1β activation in ΔripA infected cells. The addition of U0126 or SP-
600125 also reduced the release of TNF-α by macrophages upon exposure to LVS and 
LVSΔripA (Figure 5C). Finally, the combination of ERK, JNK and p38 inhibitors blocked 
LVSΔripA induced IL-1β release by macrophages more effectively than each inhibitor alone 
(Figure 5D). Taken together, these data demonstrate that wild type F. tularensis LVS interferes 
with the activation of multiple MAP kinase signaling pathways that are important for release of 
cytokines following infection.  
 
F. tularensisΔripA fails to suppress pro-inflammatory cytokine responses in vivo 
Our previous study showed that LVSΔripA is attenuated in mice as evidenced by 
a reduction in organ burden at days 1, 3 and 7 post intranasal infection when compared to LVS. 
In this study we confirm and expand this finding by monitoring mice morbidity, mortality and 
cytokine responses post infection. Mice were intranasally inoculated with LVS, LVSΔripA and 
mock/PBS and weight loss was monitored among the three experimental groups. When using a 
LD100 dose of LVS (10
5
), LVS inoculated animals exhibited severe weight loss, a measure of the 
severity of respiratory tularemia, and eventually succumbed to the disease (Figure 6A). In 
contrast, LVSΔripA inoculated animals only showed a modest weight loss when compared to 
mock/PBS treated animals. We also measured the bacterial burdens in the lungs of mice during 
the early stages of the disease (6 and 24 hours post infection). Similar levels of lung burdens 
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were observed 6 hours post infection between LVS and LVSΔripA indicating that the initial 
bacterial loads of LVS and LVSΔripA are indistinguishable (Figure 6B). By 24 hours post 
inoculation, LVS lung burdens rose to 10
6
 CFU/organ. In contrast, the lung burden of LVSΔripA 
inoculated animals did not increase beyond that of the 6 hour time point. In our previous report, 
the ripA complementation strain of LVSΔripA inoculated animals exhibited similar lung, spleen, 
and liver burdens when compared to LVS inoculated animals (Fuller et al., 2008).  
The In vitro analyses shown earlier indicate that LVSΔripA failed to suppress the 
release of IL-1β, IL-18 and TNF-α by primary mouse macrophages and human THP-1 cells. To 
determine if the absence of ripA similarly affected cytokine responses in vivo, we measured IL-
1β and TNF-α in the lungs of infected mice. After testing multiple doses of LVS∆ripA to 
determine the amount required to detect IL-1β and TNF-α in the lung (Figure 6C), we found that 
mice inoculated with 10
10
 CFU of LVS∆ripA expressed on average 5-10 fold more IL-1β than 
animals inoculated with the same number of wild type LVS (Figure 6D). Interestingly, at that 
dose of bacteria, IL-1 levels in the BALF of animals infected with wildtype LVS was 
indistinguishable from mock/PBS-treated mice. We next examined levels of TNF-α in mouse 
lungs of mock/PBS, LVS and LVS∆ripA inoculated animals. LVS∆ripA induced more TNF-α 
than LVS, but the difference was not as significant as that of IL-1β (Figure 6E). These results are 
consistent with the in vitro results obtained with mouse and human cells (Figures 1D, 3B) and 
support the effects of ripA deletion on both inflammasome and non-inflammasome mediated 
cytokines. Taken together, these data indicate that ripA is important in the circumvention of pro-
inflammatory cytokine production in vitro and in vivo. 
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3.4 Discussion 
  The innate immune response is indispensible to eradicate the invasion of 
microbial pathogens, and monocytes/macrophages are major arsenals in combating infectious 
diseases. Proper release of cytokines and chemokines by these cells is critical in the migration of 
polymorphonuclear (PMN) cells and other effector cells to the site of infection. To establish a 
successful infection, a pathogen must either evade immune surveillance or modulate host anti-
microbial response. Over time, pathogens have developed sophisticated strategies to manipulate 
host immune responses to their advantage. In this study, we demonstrated that F. tularensis 
actively suppresses the release of pro-inflammatory cytokines, and that the F. tularensis gene 
ripA is critical in this process. In response to F. tularensis LVSΔripA, macrophages are able to 
mount an effective initial response by releasing higher amounts of IL-1β, IL-18 and TNF-α when 
compared to LVS. This observation is replicated in vivo, which correlates with the reduced 
morbidity caused by LVSΔripA. This reveals an important role for the ripA gene production in 
reducing and hence evading host immunity. 
An emerging theme in the literature is that a variety of pathogens can suppress IL-
1β release by macrophages. Pseudomonas aeruginosa induces the release of IL-1β by 
macrophages in a NLRC4 dependent manner (Sutterwala et al., 2007). A subset of P. aeruginosa 
expresses the effector molecule ExoU, and this molecule inhibits Caspase-1 activation thereby 
preventing the release IL-1β and IL-18 by macrophages. Mycobacterium tuberculosis (Mtb) 
circumvents both innate and adaptive immune responses. Similar to our observations with F. 
tularensis, the Mtb gene product zmp1 prevents the activation of the inflammasome to inhibit IL-
1β processing (Master et al., 2008). Among viruses, Myxoma virus (MYXV) inhibits release of 
pro-inflammatory cytokines IL-1β, IL-18, TNF-α, IL-6 and MCP-1. MYXV encodes a pyrin 
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containing protein m103 which has been shown to bind to PYCARD and thereby disrupt the 
activation of inflammasome (Johnston et al., 2005). The m103 protein also binds NF-κB which 
suppresses the degradation of IκBα and phosphorylation of IKK. Cowpox virus, via gene crmA, 
directly inhibits Caspase-1 activity, and suppresses IL-1β response to infection (Ray et al., 1992). 
Our study with F. tularensis LVS and LVSΔripA together with these and other reports 
exemplifies the multiple strategies employed by pathogens to disrupt host immune activation of 
the production of IL-1β and other cytokines by innate immune cells. 
To elucidate the pathways by which LVS suppresses the IL-1β release by 
macrophages, we have identified PYCARD, Caspase-1 and MyD88 mediated signaling that the 
LVS strain can disrupt. Mariathasan and coworkers have shown that PYCARD and Caspase-1 
mediated host IL-1β production is key in combating F. novicida infection (Mariathasan et al., 
2005). In their study, mice lacking Pycard or Caspase-1 were far more susceptible to challenge 
by F. tularensis subspecies novicida. Moreover, mice intraperitoneally injected with IL-18 and 
IL-1β neutralization antibody prior to F. novicida challenge exhibited higher organ burdens than 
those treated with isotype control, further suggesting the importance of IL-1β and IL-18 in 
tularemia. Recently, AIM2 has been identified as candidate proteins required in F. tularensis 
induced inflammasome formation and subsequent IL-1β release (Fernandes-Alnemri et al., 2010; 
Rathinam et al., 2010). Thus far, TLR2, MyD88 and type I Interferon β have been implicated in 
F. tularensis induced host cytokine response including IL-1β by macrophages (Abplanalp et al., 
2009; Cole et al., 2007; Collazo et al., 2006; Li et al., 2006; Mariathasan et al., 2005). Our data 
suggest that F. tularensis LVSΔripA induced IL-1β is PYCARD, Caspase-1 and MyD88 
dependent and that LVS disrupts these signaling pathways. 
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In macrophages and epithelial cells, PAMPs or MAMPs activate NF-κB and MAP 
kinase pathways to initiate the pro-inflammatory responses. There are three major families of 
MAP kinase including the extracellular signal-regulated protein kinases (ERK), the c-Jun NH2-
terminal kinases (JNK) and the p38 kinases (Chang and Karin, 2001). Many pathogens have 
developed strategies to disrupt the MAP kinase pathway to subvert the immune response. Arbibe 
and coworkers demonstrated that Shigella flexneri virulence factor OspF inactivates ERK1/2 and 
p38 by preventing their phosphorylation (Arbibe et al., 2007). YopJ, a type III effector protein of 
Yersinia species has been shown to acetylate the serine and threonine residues on MAP kinase 
kinase (MAPKK) thereby interrupting the downstream MAP kinase phosphorylation (Mukherjee 
et al., 2006). Telepnev and coworkers have demonstrated that LVS may interfere with MAP 
kinase signaling pathways and that iglC is critical in this process (Telepnev et al., 2005). Our 
data suggest that LVS may be able to interfere with both the synthesis and processing of IL-1β at 
multiple points and that ripA is critical in these processes. The degradation of IκBα and 
phosphorylation of p65 is not likely the major mechanism by which ripA mediates immune 
suppression. However, LVSΔripA induced a significant increase in phosphorylation of these 
three MAP kinases when compared to wild-type LVS. Moreover, our studies showed that the 
LVSΔripA induced IL-1β and TNF-α release can be partially reduced by pre-treating cells with 
inhibitors of ERK, JNK and p38 alone, while the usage of all three inhibitors resulted in an 
additive reduction of cytokine production that approaches the lower level caused by LVS 
infection. These experiments further validated that ripA contributes to the MAP kinase 
suppressive nature of F. tularensis. LVS synergistically down-regulates the synthesis of pro-
IL1β, and prevents the processing of IL-1β, thereby resulting in strong suppression of IL-1β 
release by macrophages. 
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A specific function for RipA protein has not yet been identified. Our experiments 
using PFA-killed LVS and LVS∆ripA demonstrated that RipA-mediated suppression of the 
induction of IL-1β by LVS-infected host cells is an active process. In other words, the induction 
is not solely the result of gross morphological change in the bacterial cell or a cell surface marker 
that is present in LVS∆ripA regardless of the bacterial viability. Preliminary data from our lab 
also indicates that the outer membrane profile and LPS profile of LVS∆ripA is unchanged. 
Furthermore, our previous study demonstrated that RipA is localized to the cytoplasmic 
membrane of F. tularensis (Fuller et al., 2008). This finding suggests that RipA does not mediate 
immune response suppression by directly interfering with or binding to innate immune receptors 
or sensors. More likely RipA is interacting with another protein or proteins that interfere with the 
pro-inflammatory signaling pathways.   
In conclusion, we elucidated a mechanism by which F. tularensis actively evades 
host immune response by an analysis of the attenuated LVSΔripA strain. These results indicate 
that the ripA gene product functions by targeting two prominent innate immune circuits: the 
circumvention of the host inflammasome response and the dampening of the activation of MAP 
kinase signaling pathways. 
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3.5 Material and Methods 
Cell lines and Reagents 
Bone marrow derived macrophages were harvested from 6- to 8-week-old mice and cultured for 
7 days in 30% M-CSF conditioned media. THP-1 cells were purchased from American Type 
Culture Collection (ATCC) and cultured as described previously (Taxman et al., 2006). Anti-IL-
1β antibody was purchased from R&D Systems; anti-Iκβα, phospho-p65, phospho-ERK1/2, 
phospho-JNK, phospho-p38 from Cell Signaling; and anti-GAPDH and HRP-conjugated 
secondary antibodies from Santa Cruz Biotechnology. Detailed methods for the preparation of 
retroviral shuttle vectors, transduction and sorting to generate THP-1 cell lines stably expressing 
shRNA have been described previously (Taxman et al., 2006).  
 
Western blotting and ELISA 
Western blots were performed as described previously (Huang et al., 2009; Willingham et al., 
2007). Quantification of western blots by densitometry was performed using Adobe Photoshop. 
For ELISAs, mouse and human cell supernatants were collected 24 hours post-infection and 
assayed with BD OptEIA Mouse IL-1β, IL-18, and TNF-α ELISA Sets (BD Biosciences). 
 
Experimental Animals 
All studies were conducted in accordance with the National Institutes of Health Guidelines for 
the care and use of Laboratory Animals and the Institutional Animal Care and Use Committee 
guidelines of University of North Carolina, Chapel Hill. The generation of mice lacking 
functional Nlrp3, Nlrc4, Pycard, Caspase-1, and MyD88 has been previously described 
(Willingham et al., 2007). C57BL/6 mice were purchased from Jackson Laboratories (Maine).  
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Bacteria Preparation 
Francisella tularensis Live Vaccine Strain (LVS) was obtained from the CDC, Atlanta, GA.  
The LVS∆ripA strain has been previously described (Fuller et al. 2008). Both strains were 
maintained on chocolate agar supplemented with 1% IsoVitaleX (Becton-Dickson or BD 
Biosciences) and broth cultures were grown in Chamberlain’s defined media (Chamberlain, 
1965). All other bacteria were grown in lysogeny broth (LB) medium or brain-heart infusion 
(BHI) medium. LVS and LVSΔripA were killed by incubation for 5 minutes at room temperature 
in 1 ml of 2% paraformaldehyde
 
in PBS, washed three times with PBS, and resuspended in 
DMEM with 10% PBS. All cultures were grown at 37°C.  
 
Francisella tularensis infection of mouse primary macrophages and human monocytic cell lines 
Cells were challenged with LVS or LVSΔripA and incubated for various time periods at 37oC at 
indicated MOI. Cell supernatants were harvested at select time points for cytokine analysis. For 
pharmacological assessments, cells were treated with Y-VAD-fmk (10 µM), U0126, SP-600125, 
and SB-202190 (0.5 – 25 µM) as previously described (Taxman et al., 2006).  
 
In vivo Francisella tularensis infection 
F. tularensis LVS from an overnight culture in Chamberlain’s media were centrifuged to pellet 
cells and resuspended in phosphate-buffered saline (PBS).  These suspensions were enumerated 
by Klett reading and diluted further in tissue culture medium for the inoculums.  Wild-type 8- to 
10-week-old female C57BL/6 mice were anethesized with avertin, as determined by insensitivity 
to a toe pinch.  Mice were then infected intranasally with bacterial inoculums in a 50 μl volume 
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in PBS applied to the nares (This is the proper description of the procedure.) of each mouse by 
pipette. Mice were monitored for recovery from anesthesia.  
 
Statistical Analysis 
Data are presented as the mean ± standard deviation (s.d). Statistical significance for single data 
points was assessed by the Student’s two tailed t test. In all cases, a p value of less than 0.05 was 
considered statistically significant. 
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Figure 3.1: Francisella tularensis LVS ΔripA fails to suppress pro-inflammatory cytokine 
release by primary mouse macrophages. 
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Figure 3.1 Francisella tularensis LVS ΔripA fails to suppress pro-inflammatory cytokine release 
by primary mouse macrophages. 
A. IL-1β secretion levels in mouse macrophages following exposure to F. tularensis LVS, 
Salmonella typhi, Klebsiella pneumoniae, or Shigella flexneri at MOI 50 for 24 hours were 
determined by ELISA. Data represent mean ± standard deviation (s.d.) for at least three 
independent experiments performed in triplicate. A representative experiment is shown. *, p < 
0.01 
B. IL-1β secretion levels in mouse macrophages exposed to LVS, LVSΔripA, or LVSΔripA 
complementation strain at MOI 50 and 500 for 24 hours. Data represent mean ± s.d. for at least 
three independent experiments performed in triplicate. A representative experiment is shown. *, 
p < 0.01 
C. IL-18 secretion levels in mouse macrophages exposed to LVS, LVSΔripA, or LVSΔripA 
complementation strain at MOI 50 and 500 for 24 hours. Data represent mean ± s.d. for at least 
three independent experiments performed in triplicate.  A representative experiment is shown. *, 
p < 0.01 
D. TNF-α secretion levels in mouse macrophages exposed to LVS, LVSΔripA, or LVSΔripA 
complementation strain at MOI 50 and 500 for 24 hours. Data represent mean ± s.d. for at least 
three independent experiments performed in triplicate.  A representative experiment is shown. *, 
p < 0.01 
E. IL-1β secretion levels in mouse macrophages exposed to live and PFA-treated LVS and 
LVSΔripA at MOI 50 and 500 for 24 hours. Data represent mean ± s.d. for at least three 
independent experiments performed in triplicate.  A representative experiment is shown. *, p < 
0.01 
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Figure 3.2: LVSΔripA induced pro-inflammatory cytokines are regulated by inflammasome 
components and MyD88. 
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Figure 3.2 LVSΔripA induced pro-inflammatory cytokines are regulated by inflammasome 
components and MyD88. 
A. IL-1β secretion levels in mouse macrophages derived from Wt, Pycard-/-, Caspase-1-/-, 
MyD88
-/-
, Nlrp3
-/-
, and Nlrc4
-/-
 mice exposed to LVS and LVSΔripA at MOI 500 for 24 hours as 
assessed by ELISA of cell supernatants.  Data represent mean ± s.d. for at least three 
independent experiments performed in triplicate.  A representative experiment is shown. *, p < 
0.01 
B. IL-18 secretion levels in macrophages derived from Wt, Pycard
-/-
, Caspase-1
-/-
, MyD88
-/-
, 
Nlrp3
-/-
, and Nlrc4
-/-
 mice exposed to LVS and LVSΔripA at MOI 500 for 24 hours.  Data 
represent mean ± s.d. for at least three independent experiments performed in triplicate. A 
representative experiment is shown. *, p < 0.01 
C. TNF-α secretion levels in mouse macrophages derived from Wt, Pycard-/-, Caspase-1-/-, 
MyD88
-/-
, Nlrp3
-/-
, Nlrc4
-/-
 exposed to LVS and LVSΔripA at MOI 500 for 24 hours. Data 
represent mean ± s.d. for at least three independent experiments performed in triplicate.  A 
representative experiment is shown. *, p < 0.01 
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Figure 3.3: LVS ripA is necessary for suppression of pro-inflammatory cytokine release by 
human THP-1 cells. 
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Figure 3.3 LVS ripA is necessary for suppression of pro-inflammatory cytokine release by 
human THP-1 cells. 
A. IL-1β secretion levels in THP-1 cells exposed to LVS and LVSΔripA at MOI 500 for 24 
hours. Data represent mean ± s.d. for at least three independent experiments performed in 
triplicate. A representative experiment is shown. *, p < 0.01 
B. TNF-α secretion levels in THP-1 cells exposed to LVS and LVSΔripA at MOI 500 for 24 
hours. Data represent mean ± s.d. for at least three independent experiments performed in 
triplicate. A representative experiment is shown. *, p < 0.01 
C. IL-1β secretion levels in THP-1 cells expressing stable Sh-Ctrl, Sh-PYCARD and Sh-NLRP3 
exposed to LVS and LVSΔripA at MOI 500 for 24 hours. Data represent mean ± s.d. for at least 
three independent experiments performed in triplicate.  A representative experiment is shown. *, 
p < 0.01 
D. IL-1β secretion levels in mock pre-treated THP-1 cells and cells pre-treated with Y-VAD and 
exposed to LVS and LVSΔripA at MOI 500 for 24 hours. Data represent mean ± s.d. for at least 
three independent experiments performed in triplicate.  A representative experiment is shown. *, 
p < 0.01  
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Figure 3.4: Francisella tularensis LVS suppresses IL-1β response in macrophages by interfering 
with IL-1β synthesis and processing. 
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Figure 3.4 Francisella tularensis LVS suppresses IL-1β response in macrophages by interfering 
with IL-1β synthesis and processing. 
A. Western blot analysis of IL-1β expression in mouse macrophages exposed to LVSΔripA at 
MOI 500 for 0, 5, 15, 20, 30, 45, 60, 120, 180 minutes and 24 hours. At least three independent 
experiments were performed. A representative western blot is shown. 
B. Western blot analysis of IL-1β expression in mouse macrophages exposed to LVS and 
LVSΔripA at MOI 500 for 0, 15, 30, 60 and 120 minutes. At least three independent experiments 
were performed. A representative western blot is shown. 
C. Quantification of the western blot shown in (B) by densitometry.  
D. Western blot analysis of IL-1β expression in macrophages derived from Pycard-/- mice 
following exposure to LVS and LVSΔripA at MOI 500 for 0, 30, 60 and 120 minutes. At least 
three independent experiments were performed. A representative western blot is shown.  
E. Quantification of the western blot shown in (D) by densitometry.  
F. Western blot analysis of IκBα and phospho-p65 expression in mouse macrophages exposed to 
LVS and LVSΔripA at MOI 500 for 0, 15, 30 and 60 minutes. At least three independent 
experiments were performed. A representative western blot is shown. 
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Figure 3.5: Francisella tularensis LVS suppresses pro-inflammatory cytokine release by 
disrupting MAP kinase signaling pathways  
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Figure 3.5 Francisella tularensis LVS suppresses pro-inflammatory cytokine release by 
disrupting MAP kinase signaling pathways  
 
A. Western blot analysis of phospho-ERK1/2, phospho-JNK, phospho-p38 and GAPDH in 
mouse macrophages exposed to LVS and LVSΔripA at MOI 500 for 0, 15, 30 and 60 minutes. 
At least three independent experiments were performed. A representative western blot is shown.  
B. IL-1β secretion levels in mouse macrophages pre-treated with ERK inhibitor U0126 and JNK 
inhibitor SP-600125 and exposed to LVS and LVSΔripA at MOI 500 for 24 hours. Data 
represent mean ± s.d. for at least three independent experiments performed in triplicate.  A 
representative experiment is shown. *, p < 0.01 
C. TNF-α secretion levels in mouse macrophages pre-treated with U0126 or SP-600125 and 
exposed to LVS or LVSΔripA at MOI for 24 hours. Data represent mean ± s.d. for at least three 
independent experiments performed in triplicate.  A representative experiment is shown. *, p < 
0.01 
D. IL-1β secretion levels in mouse macrophages pre-treated with, U0126, SP-600125, p38 
inhibitor SB-202190 or a combination of U0126, SP-600125 and SB-202190 and exposed to 
LVS or LVSΔripA at MOI 500 for 24 hours. Data represent mean ± s.d. for at least three 
independent experiments performed in triplicate. A representative experiment is shown. *, p < 
0.01 
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Figure 3.6: LVSΔripA fails to suppress pro-inflammatory cytokine responses in a mouse 
respiratory tularemia model. 
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Figure 3.6 LVSΔripA fails to suppress pro-inflammatory cytokine responses in a mouse 
respiratory tularemia model. 
A. Body weights of mice intranasally (i.n.) exposed to mock, LVS and LVSΔripA at dose of 105 
for 1-10 days. At least two independent experiments with more than 5 animals per group were 
performed. A representative experiment is shown. 
B. Lung organ burdens of mice i.n. exposed to LVS and LVSΔripA at a dose of 105 for 6 and 24 
hours. At least three independent experiments with more than 4 animals per group were 
performed. A representative experiment is shown. 
C. IL-1β levels in mouse bronchoalveolar lavage fluid (BALF) following i.n. exposure to 
LVSΔripA at increasing doses for 24 hours. Data represent mean ± s.d. for at least two 
independent experiments with more than 3 animals per group. A representative experiment is 
shown. 
D. IL-1β levels in mouse BALF following mock treatment or i.n. exposure to LVS or LVSΔripA 
for 24 hours. Data represent mean ± s.d. for at three independent experiments with more than 6 
animals per group. All data are shown. *, p < 0.01 
E. TNF-α levels in mouse BALF following mock treatment or i.n. exposure LVS or LVSΔripA 
for 24 hours. Data represent mean ± s.d. for at least three two independent experiments with 
more than 6 animals per group. A representative experiment is shown. 
 
 
 
 
 
  
 
 
Chapter IV 
 
CONCLUSIONS 
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4.1 P. gingivalis and necrosis 
 In chapter II, we demonstrated the critical role of NLRP3 and the adaptor 
molecule PYCARD in P. gingivalis orchestrated macrophage host response. First, P. gingivalis 
induced cell death in THP-1 human monocytic cells and this process required NLRP3 and 
PYCARD as evidenced by Sh-RNA knockdown studies. P. gingivalis induced cell death 
appeared to have morphological features consistent with necrosis including a compromised cell 
membrane and the release of intracellular content. Furthermore, P. gingivalis induced cell death 
was not blocked by caspase inhibitors including Y-VAD (caspase-1 inhibitor) and Z-VAD (pan 
caspase inhibitor). This finding is significant because while P. gingivalis induced cell death is 
NLRP3 and PYCARD dependent but not caspase independent, P. gingivalis induced IL-1β 
release is NLRP3, PYCARD and caspase dependent. Ample literature thus far has demonstrated 
that most bacteria induced a type of inflammasome mediated cell death called pyroptosis 
(Bergsbaken 2009). The removal of various NLR proteins, PYCARD and caspase-1 abrogates 
the execution of pyroptosis (Bergsbaken 2009). P. gingivalis is within a unique class of 
pathogens, including Shigella flexneri, Neisseria gonorrhoeae, and Staphylococcus aureus α-
hemolysin, that induces a caspase-1 independent necrotic cell death and thus does not follow this 
caspase-1 dependent pyroptosis (Willingham 2007 and Duncan 2009, Craven 2009). Further 
studies are warranted to elucidate the mechanisms of P. gingivalis induced cell death in human 
monocytic cells downstream of NLRP3 and PYCARD. Perhaps this would help identify novel 
interacting partners of NLRP3 / PYCARD and their downstream functions. 
 
4.2 PYCARD speck / pyroptosome formation in response to bacterial infection 
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 In addition to inducing necrosis, P. gingivalis was shown to induce PYCARD 
speck formation. In un-stimulated monocytes / macrophages, PYCARD is expressed 
ubitiquously in the cytoplasm. Upon stimulation, PYCARD is redistributed toward a peri-nuclear 
location and congregates there. The result is a speck highly enriched with PYCARD peri-
nuclearly. Fernandes-Alnemri and coworkers described this phenomenon and termed it the 
PYCARD pyroptosome (Fernandes-Alnemri 2007). In addition to describing the pyroptosome 
mediated cell death, the authors equated the formation of the pyroptosome (PYCARD speck) to 
the activation of inflammasome. Prior to this study, the only marker of inflammasome activation 
was the processing of caspase-1 (the emergence of processed caspase-1, p10 or p20 by Western 
blotting analysis). Our study demonstrated, for the first time, that pathogens such as P. gingivalis 
induce PYCARD speck formation and that this process is dependent on NLRP3. Since then, a 
number of studies mainly lead by Fernandes-Alnemri and coworkers have demonstrated that 
other pathogens such as F. tularensis also induced pyroptosome formation (Fernandes-Alnemri 
2010), and this process requires AIM2, analogous to P. gingivalis induced a NLRP3 dependent 
PYCARD speck formation. To this date, the components of the pyroptosome / PYCARD speck 
other than PYCARD remain unclear. The only study that has attempted to answer this question 
was by Fernandes-Alnemri and coworkers. Using cells over-expressing AIM2, they showed that 
AIM2, PYCARD and F. tularensis DNA co-localized in the pyroptosome (Fitzgerald 2009, 
Fernandes-Alnemri 2009). Our attempts proved inconclusive on whether endogenous NLRP3 co-
localized with PYCARD after P. gingivalis stimulation (unpublished). Future studies are 
warranted to identify novel components of PYCARD speck formation induced by P. gingivalis 
and bacteria that activated the NLRC4 inflammasome such as Salmonella typhi.  
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4.3 P. gingivalis and the IL-1β family of cytokines 
 The critical role of the inflammasome in P. gingivalis orchestrated innate immune 
response was first identified by our group. Taxman and coworkers showed that P. gingivalis 
induced the release of IL-1β in a PYCARD dependent manner in THP-1 monocytic cells 
(Taxman 2006). In chapter II, we established that P. gingivalis induced IL-1β is also mediated by 
NLRP3 and this process is caspase-1 dependent. Since then two studies have further 
characterized the importance of inflammasome signaling in periodontal disease. A study by 
Bostanci and coworkers evaluated the relative expression of NLRP3, NLRP2, PYCARD, IL-1β 
and IL-18 in tissue samples isolated from healthy subjects, patients with gingivitis, patients with 
chronic periodontitis and patients with generalized aggressive periodontitis (Bostanci 2009). 
Their study revealed that tissues isolated from all three types of periodontal disease patients 
expressed significant higher levels of NLRP3 compared to tissues isolated from healthy subjects. 
A similar trend was observed in regards to NLRP2, albeit the degree of elevation was modest. 
However, the expression of PYCARD was not statistically different among the four groups. This 
result may appear to be surprising initially since the authors also found that both IL-1β and IL-18 
mRNA levels were higher in patient samples with periodontal disease compared to healthy 
controls. The authors went on to test the message levels of NLRP3, NLRP2, PYCARD, IL-1β 
and IL-18 in monocytic cells during a P. gingivalis in vitro infection. The mRNA levels of 
NLRP3, IL-1β and IL-18 were raised post bacterial exposure in a dose dependent manner 
whereas a reverse pattern is observed with NLRP2 and PYCARD. Taxman and coworkers 
demonstrated that both the message and protein levels of PYCARD decreased post P. gingivalis 
exposure in a time dependent manner (Taxman 2006). Perhaps the cells utilize PYCARD as a 
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target in a negative feedback system to prevent an overzealous immune response to prevent the 
destruction of neighboring tissue.  
 
 In a recent study, Yilmaz and coworkers demonstrated that the mRNA level of 
NLRP3 partially decreased post P. gingivalis exposure in gingivalis epithelial cells (GEC) 
whereas the expression of PYCARD message level remained largely unchanged during the same 
treatment (Yilmaz 2009). This result is different than that of the work by Taxman et.al. and 
Bostanci et.al. where the expression of PYCARD decreased post P. gingivalis exposure. This 
difference could partially be attributed to the difference in cell type. In our hands, myeloid cells 
express much higher levels both NLRP3 and PYCARD than epithelium derived cells. Yilmaz 
and coworkers also demonstrated that P. gingivalis and ATP induced an NLRP3 dependent IL-
1β release, but P. gingivalis alone was not sufficient to generate a release of IL-1β in GECs. This 
appears to be in contrast to our data where we showed P. gingivalis induced a robust IL-1β 
release in THP-1 cells and this process is NLRP3 and PYCARD dependent. Several possibilities 
may explain this difference. First, it is documented that human blood monocytes only require a 
TLR agonist stimulation to release IL-1β (Netea 2009). This is due to the fact that human 
monocytes possess constitutively activated caspase-1 that automatically processes pro-IL-1β 
after synthesis. In contrast, mouse macrophages require both signal 1 (NF-κB and/or MAP 
kinase mediated pro-IL-1β synthesis) and signal 2 (the activation of inflammasome) for the 
release of mature IL-1β. In the study by Yilmaz and coworkers, GECs appeared to require both 
signal 1 and 2 to release IL-1β and P. gingivalis alone was insufficient to activate inflammasome 
(Yilmaz 2010). In our unpublished study, we exposed P. gingivalis to murine bone marrow 
derived macrophages (BMDM) and were surprised to find no IL-1β release post infection by 
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macrophages. However, P. gingivalis together with ATP did induce a significant level of IL-1β 
release by BMDM. Western blotting analysis revealed that P. gingivalis alone induced abundant 
pro-IL-1β (33KD), but no processed IL-1β (17KD) was observed. In contrast, in the cell lysates 
treated with P. gingivalis and ATP, both pro-IL-1β and processed IL-1β were observed 
suggesting that BMDM lacks constitutively activated caspase-1, and therefore needs ATP to 
activate an NLRP3 dependent inflammasome assembly. The inability to activate the 
inflammasome makes P. gingivalis a unique bacteria since most Gram-negative bacteria are able 
to activate both signal 1 and 2. To determine whether other oral Gram-negative bacteria also lack 
inflammasome inducibility, we exposed Fusobacterium nucleatum to murine macrophages and 
measured IL-1β response. F. nucleatum alone induced significant IL-1β release by murine 
BMDM in the absence of ATP and this process was dependent on NLRP3 and PYCARD 
(unpublished). It is still unclear whether P. gingivalis just does not activate inflammasome 
formation or it actively suppresses the activation of inflammasome. This question can be 
answered by co-infection of macrophages with P. gingivalis and another IL-1β release 
stimulating bacteria such as F. nucleatum and measuring the IL-1β release. 
 
 
4.4 RipA is critical in F. tularensis suppression of Inflammasome activation 
 While chapter II shows a pathogen that can induce inflammasome activation, in 
chapter III, by using a F. tularensis LVS strain deficient of gene ripA (LVSΔripA), we 
uncovered a mechanism by which F. tularensis suppresses host innate immune response. Both 
murine and human macrophage / monocytes exposed to LVSΔripA released a 5-10 fold higher 
IL-1β and IL-18 level and a 2-3 fold higher TNF-α level than wild type LVS. LVSΔripA induced 
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IL-1β and IL-18 were PYCARD, caspase-1 and MyD88 dependent whereas the TNF-α response 
was dependent on MyD88 only. Furthermore, LVSΔripA fail to suppress the synthesis of pro-IL-
1β and processing of IL-1β. To elucidate the mechanism by which LVS suppresses the host 
production of pro-IL-1β and TNF-α, we compared the induction profile of NF-κB and MAP 
kinase signaling pathways in macrophages treated with LVS and LVSΔripA. While the 
activation pattern of NF-κB was comparable between LVS and LVSΔripA, the deletion of ripA 
significantly impaired the suppression of MAP kinase activation by LVS. Furthermore, pre-
treatment with MAP kinase inhibitors significantly reduced the LVSΔripA induced IL-1β and 
TNF-α. This suggests that the suppression of MAP kinase pathways by LVS directly impairs the 
host macrophages’ ability to secrete pro-inflammatory cytokines. Lastly, we showed LVSΔripA 
induced a 5-10 fold higher IL-1β level and at least 2 fold higher TNF-α level compared to LVS 
in the lung of animals intranasally infected with F. tularensis.  
 The first study demonstrating the role of the inflammasome in F. tularensis 
pathogenesis was carried out by Mariathasan and coworkers (Mariathasan 2005). In this study, 
the authors demonstrated that F. novicida induced PYCARD and caspase-1 dependent IL-1β and 
IL-18 release by mouse macrophages. Consequently, animals deficient of either PYCARD or 
caspase-1 were far more susceptible than their wild type counterparts during an intradermal 
infection of F. novicida. This study did not, however, identify the NLR or specific sensor 
required for the formation of Francisella induced inflammasome. Two recent studies have 
identified AIM2 as the putative intracellular sensor of the F. novicida induced inflammasome 
and the subsequent IL-1β release (Rathinam 2010, Fernandes-Alnemri 2010). Fernandes-
Alnemri and coworkers further demonstrated that F. novicida DNA was found in the cytoplasm 
of infected macrophages, and it co-localizes with AIM2 and PYCARD in the pyroptosome. This 
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is the first evidence suggesting that the PYCARD speck / pyroptosome could be a site where host 
cells detect and transport bacterial DNA to activate the formation of the inflammasome in order 
to execute IL-1β release and cell death. However, the mechanism by which this process occurs 
remains elusive. It is tempting to theorize that LVS suppression of IL-1β release is due to its 
modulation of the AIM2 mediated pathways, thereby avoiding its own DNA being sensed by 
AIM2, and that the loss of ripA abrogates this mechanism. Since the AIM2 detection of 
Francisella DNA was carried out using F. novicida, the next logical step is to test whether 
LVSΔripA induced IL-1β is blocked in AIM2 deficient macrophages. 
 
 
4.5 Other F. tularensis virulence factors that suppress host immune response 
 While a number of studies have described the immune suppressive nature of F. 
tularensis, two studies specifically identified F. tularensis virulence genes that directly or 
indirectly suppress host macrophage cytokine response. Using an in vivo negative selection 
screen, Weiss and coworkers identified a number of F. novicida genes that contribute to 
pathogensis in mice (Weiss 2007). Two genes necessary for virulence but not required for 
intracellular bacterial replication were identified; they were subsequently demonstrated to curb 
F. novicida induced IL-1β and cell death in murine macrophages. Specifically, F. novicida genes 
FTT0748 and FTT0584 have been shown to be involved in F. novicida suppression of cell death 
and cytokine release. The authors showed that transposon mutants of FTT0748 and FTT0584 
induced higher levels of IL-1β release by macrophages compared to wide type F. novicida. 
FTT0748 and FTT0584 induced IL-1β was completely ablated in macrophages deficient of 
PYCARD and caspase-1 suggesting that these genes are critical in the F. novicida manipulation 
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of inflammasome activation and its downstream targets. They also reported that FTT0748 and 
FTT0584 mutants replicate with similar efficiency compared to wild type F. novicida. While 
these transposon mutants provide an effective screening tool to identify potential Francisella 
virulence genes, gene deletion mutants and their complements should be constructed to ensure 
the cause/effects of these genes in contributing to virulence. FTT0748 encodes a protein 
homologous to the IclR family of transcription regulators. Interestingly, LVS deficient of 
FTT0748/iclr did not induce a higher level of IL-1β compared to wild type LVS (manuscript by 
Mortenson et.al, submitted to Infection and Immunity).  Presently, it is still unclear whether 
FTT0748 and FTT0584 contribute directly or indirectly to the Francisella suppression of IL-1β 
release by macrophages.  
 
 In a recent study, Platz and coworkers demonstrated that F. tularensis LVS 
deficient in an additional virulence factor, tolC, induced a 5-10 fold higher level of IL-1β in 
human macrophages compared to wild type LVS (Platz 2010). This result is very similar to that 
of LVSΔripA and LVS. In addition, LVSΔtolC also induced higher levels of CCL2 and CXCL8 
compared to wild type LVS. It would be interesting to test whether these results can be replicated 
by LVSΔripA and whether LVSΔtolC would generate a higher TNF-α response than LVS. 
Unlike many intracellular bacteria, F. tularensis lacks a Type III or IV secretion system but does 
possess a Type I secretion system to deliver various toxins and virulence factors (Gil 2006). The 
Type I secretion system consists of an outer membrane channel, membrane fusion proteins and 
an inner membrane pump. F. tularensis TolC, homologous to E. coli. TolC, is a component of 
the outer membrane channel. RipA is found on the inner membrane of the bacterium. While it is 
unknown whether RipA plays a role in a functioning Francisella Type I secretion system, it 
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would be worthwhile to test whether a functioning Francisella Type I secretion system can be 
found in LVSΔripA. 
 
 
4.6 Concluding remarks 
 This dissertation mainly focused on the central theme of understanding the roles 
of NLR and inflammasome components in pathogen induced host immune response. The first 
half centered on identifying novel NLRs, inflammasome components mediating P. gingivalis 
induced IL-1β release and cell death in human monocytic cells. The second half focused on 
understanding how pathogens such as F. tularensis suppress host immune response by curbing 
inflammasome activation and MAP kinase induction. These studies contribute to the 
understanding of how a host detects and mounts a defense when confronted with pathogens and 
how pathogens use a myriad of pathways to evade host responses. 
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